PPARγ modulators and methods of use
Patent Information
- Application Number
- JP2023527349
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-11-09
- Filing Date
- 2021-11-08
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-11-08
AI Technical Summary
Muscle-invasive bladder cancer (MIBC), particularly the luminal subtype, has limited treatment options due to low response rates to chemotherapy and immunotherapy, with genomic alterations in the RXRα/PPARγ pathway contributing to tumor growth and immunosuppression, necessitating novel therapeutic approaches.
Development of compounds targeting the RXRα and/or PPARγ pathway, specifically represented by formula (I) compounds and their pharmaceutically acceptable salts, which act as TR-FRET inverse agonists to inhibit PPARγ/RXRα, thereby restoring immune surveillance and sensitivity to immunotherapy.
The compounds effectively target the RXRα/PPARγ pathway, enhancing immune cell infiltration and sensitivity to immunotherapy, providing a therapeutic option for chemoresistant and immunotherapy-resistant luminal-type bladder cancers.
Smart Images

Figure 2022099144000001 
Figure 2022099144000002 
Figure 2022099144000003
Abstract
Description
[Technical Field]
[0001] This application claims the benefit of priority to U.S. Provisional Patent Application No. 63 / 111,354, filed November 9, 2020, the contents of which are incorporated herein by reference in their entirety.
[0002] Disclosed herein are novel compounds and pharmaceutical compositions containing such compounds that may be useful in the treatment of cancer, particularly cancers for which agents targeting the RXRα and / or PPARγ pathways are known to be useful. [Background technology]
[0003] Muscle-invasive bladder cancer (MIBC) is an aggressive and potentially fatal disease with limited treatment options. Although chemotherapy and immunotherapy have been approved for the treatment of locally advanced or metastatic bladder cancer, the majority of patients either fail to respond or experience only short-term responses (Seiler et al., 2017 Eur Urology; Robertson et al., 2017 Cell). This suggests that further efforts are needed to identify novel therapies that may benefit patients who currently do not respond to existing standard-of-care (SoC) therapies.
[0004] Recent studies have revealed that not all advanced bladder cancers are created equal. Deep gene expression and genomic analyses have revealed distinct molecular subtypes of MIBC, including basal and luminal subtypes (Choi et al., 2014 Cancer Cell; Kardos et al., 2016 JCI Insight; Kamoun et al., 2020 Eur Urology), which possess unique tumor-specific and microenvironmental characteristics. Much like luminal breast and prostate cancers, luminal bladder cancers tend to be slow-growing, less immune-infiltrative, and have lower response rates to both chemotherapy and immunotherapy (Robertson et al., 2017 Cell). Currently, only suboptimal therapies are available for luminal disease, necessitating concerted efforts to identify and exploit novel luminal lineage-specific therapeutic nodes.
[0005] Genomic alterations in the RXRα / PPARγ pathway are prominent in the majority of luminal bladder cancers, including a recurrent mutation at serine 427 in RXRα (S427F / Y), a hotspot mutation at threonine 475 in PPARγ (T475M), and amplification / overexpression of PPARγ (Guo et al., 2013 Nature Genetics; Van Allen et al., 2014 Cancer Discovery). These genomic alterations enhance the PPARγ / RXRα-dependent transcriptional program in MIBC (Halstead et al., 2017 eLife; Korpal et al., 2017 Nat Communications; Goldstein et al., 2017 Cancer Research). In addition, PPARγ is the only gene that exhibits reduced proliferation after genetic / pharmacological inhibition of PPARγ. activeOnly in luminal bladder cancer cell lines (Halstead et al., 2017 eLife; Goldstein et al., 2017 Cancer Research). Thus, activation of this pathway is associated with a growth dependency on RXRα / PPARγ. Subsequent analysis of the functional role of PPARγ in luminal cells revealed a critical role in promoting energy production through enhanced glucose and lipid metabolism (Liu et al., 2019 Nat Communications), which may contribute to the PPARγ dependency observed in genomically altered luminal cells.
[0006] In addition to this tumor-specific role of PPARγ in PPARγ-altered luminal bladder cancer, recent studies suggest that activated PPARγ / RXRα suppresses inflammatory cytokine expression and immune cell infiltration (Korpal et al., 2017 Nat Communications; Kardos et al., 2016 JCI Insight). Several clinical datasets and in vivo tumor models have demonstrated that PPARγ High / RXRα S427F / Y CD8 + It has been shown to attenuate T cell infiltration and confer partial resistance to immune checkpoint inhibitors. Knockdown of PPARγ or RXRα and pharmacological inhibition of PPARγ significantly increase cytokine expression, suggesting therapeutic approaches to restore immune surveillance and sensitivity to immunotherapy (Korpal et al., 2017 Nat Communications). Collectively, these studies suggest that PPARγ acts as a tumor cell-intrinsic "immuno-oncogene" that functions by promoting tumor cell growth, enhancing energy production, and increasing tumor cell survival through immunosuppression. Summary of the Invention [Problem to be solved by the invention]
[0007] Accordingly, disclosed herein are compounds that can target the RXRα and / or PPARγ pathways. [Means for solving the problem]
[0008] As used herein, the term "compound of formula (I): [ka] (In the formula, Ar 1 teeth, [ka] is selected from: Y 1 N and CX 1 Selected from X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, halogen, cyano, and optionally substituted alkoxy; and R 4 is selected from hydrogen and optionally substituted alkyl; Y 2 is CX 2 and N, and Y 3 is NH, or Y 2 is NH, and Y 3 is CX 2 or X 2 is selected from hydrogen and halogen; Ring A is selected from saturated 6-9 membered cyclic rings optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl; R 1 is -(CHR 5 ) k -(CR 6 R 7 )n -(O) m - Ring B, wherein k is 0 or 1, n is 0 or 1, m is 0 or 1; R 5 is selected from hydrogen and optionally substituted alkyl; R 6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen, and Ring B is optionally substituted aryl; optionally substituted heteroaryl; optionally substituted cycloalkyl; optionally substituted heterocycloalkyl; optionally substituted cycloalkenyl, and optionally substituted heterocycloalkenyl selected from; and R 2 is selected from hydrogen and optionally substituted alkyl and pharmaceutically acceptable salts thereof. DETAILED DESCRIPTION OF THE INVENTION
[0009] In some embodiments, R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, chlorine, fluorine, cyano, and optionally substituted alkoxy.
[0010] In some embodiments, R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n - Ring B, wherein k, n, R 5 , R 6 , R 7and ring B are as defined in formula (I). 1 is -(CHR 5 ) k -(CR 6 R 7 ) n - Ring B, wherein k, n, R 5 and ring B are as defined in formula (I), and R 6 and R 7 is fluorine.
[0011] In some embodiments, R 2 is selected from hydrogen and C1-C3 alkyl.
[0012] In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC activity of less than 1000 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value of less than 500 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value of less than 250 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value in the range of 0.1 nM to 1000 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value in the range of 0.1 nM to 500 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value in the range of 0.1 nM to 250 nM. 50 It has a value.
[0013] As used herein, "TR-FRET inverse agonist AC" refers to a compound that is 50"value" refers to the AC value obtained when measuring Co-R peptide recruitment to PPARγ using the TR-FRET assay disclosed herein. 50 Points to a value.
[0014] Also disclosed herein is a pharmaceutical composition comprising at least one entity selected from the compound of formula (I) and its pharmaceutically acceptable salts. In some embodiments, the pharmaceutical composition further comprises at least one pharmaceutically acceptable carrier.
[0015] Also disclosed herein is a method for treating a subject with cancer, comprising administering to the subject a therapeutically acceptable amount of at least one entity selected from a compound of Formula (I) and / or a pharmaceutically acceptable salt thereof. In some embodiments, the cancer is selected from advanced bladder cancer, luminal breast cancer, prostate cancer, luminal bladder cancer, basal bladder cancer, and / or cancer with an altered RXRα and / or PPARγ pathway. In some embodiments, the cancer is chemoresistant and / or immunotherapy resistant.
[0016] Also disclosed herein is the use of at least one entity selected from the compounds of formula (I) and pharmaceutically acceptable salts thereof in a method of therapeutic treatment, for example a method of treating cancer. Also disclosed herein is at least one compound selected from the compounds of formula (I) and pharmaceutically acceptable salts thereof for use in the preparation of a medicament.
[0017] As used herein, the following definitions shall apply unless otherwise indicated.
[0018] As described herein, compounds can be substituted with one or more substituents, such as those generally described herein or exemplified by the detailed classes, subclasses, and species of this disclosure. Generally, the term "substituted" refers to the replacement of a hydrogen radical in a given structure with a designated substituent group. Unless otherwise specified, a substituted group can have a substituent at each substitutable position of the group, and when more than one position in any given structure can be substituted with more than one substituent selected from a designated group, the substituents can be the same or different at every position. Combinations of substituents envisioned by this disclosure are those that result in the formation of stable or chemically feasible compounds. The term "substituted" includes, for example, situations in which at least one hydrogen atom is replaced by at least one non-hydrogen atom, such as a halogen atom (including perhalogenated), for example, F, Cl, Br, and I; deuterium; a carbon atom in groups such as alkyl groups and cyano groups; an oxygen atom in groups such as hydroxyl groups, alkoxy, and ester groups; a sulfur atom in groups such as thiol groups, thioalkyl groups, cyano groups, sulfone groups, sulfonyl groups, and sulfoxide groups; a nitrogen atom in groups such as amines, amides, alkylamines, dialkylamines, arylamines, alkylarylamines, diarylamines, N-oxides, imides, and enamines; a silicon atom in groups such as trialkylsilyl groups, dialkylarylsilyl groups, alkyldiarylsilyl groups, and triarylsilyl groups; and other heteroatoms in various other groups. "Substituted" also includes, for example, situations in which at least one hydrogen atom in any of the above groups is replaced by a higher order bond (e.g., a double or triple bond) to a heteroatom, such as the oxygen in oxo, carbonyl, carboxyl, and ester groups; and the nitrogen in groups such as imine, oxime, hydrazone, and nitrile.
[0019] "Isomers" refer to compounds having the same number and kinds of atoms, and therefore the same molecular weight, but differing in the arrangement or configuration of those atoms. "Stereoisomers" refer to compounds having the same atom connectivity, but with their atoms arranged in different spaces. "Diastereoisomers" or "diastereomers" refer to stereoisomers that are not enantiomers. "Enantiomers" refer to stereoisomers that are non-superimposable mirror images of each other. "Geometric isomers" refer to cis-trans isomers with different orientations of groups relative to double bonds or ring atoms or central atoms.
[0020] Enantiomers as taught herein can include "enantiomerically pure" isomers in which one or more particular chiral centers are substantially dominated by a single enantiomer, e.g., 90%, 92%, 95%, 98%, 99% or more, or 100% dominated by a single enantiomer. "Chiral center" or "chiral center" refers to a tetrahedral carbon atom containing four different substituents.
[0021] "Stereomerically pure," as used herein, refers to a compound or composition thereof that contains one stereoisomer of a compound and is substantially free of other stereoisomers of that compound. For example, a stereomerically pure composition of a compound having one chiral center will be substantially free of the opposite enantiomer of that compound. In some embodiments, a stereomerically pure composition of a compound having two chiral centers will be substantially free of diastereomers of that compound and substantially free of the opposite enantiomer. In some embodiments, a stereomerically pure compound is greater than about 80% by weight of one stereoisomer of the compound and less than about 20% by weight of the other stereoisomer of the compound, such as greater than about 90% by weight of one stereoisomer of the compound and less than about 10% by weight of the other stereoisomer of the compound, or even greater than about 95% by weight of one stereoisomer of the compound and less than about 5% by weight of the other stereoisomer of the compound, or even greater than about 97% by weight of one stereoisomer of the compound and less than about 3% by weight of the other stereoisomer of the compound. The terms "R" and "S" as descriptive of isomers are symbols representing the stereochemical configuration at an asymmetrically substituted carbon atom. The designation of "R" or "S" for an asymmetrically substituted carbon atom is made by application of the Cahn-Ingold-Prelog precedence rules, as known to those skilled in the art, and is set forth in Section E, Stereochemistry, of the International Union of Pure and Applied Chemistry (IUPAC) Rules for the Nomenclature of Organic Chemistry.
[0022] "Ar" or "aryl" refers to an aromatic carbocyclic moiety having one or more closed rings. Non-limiting examples include phenyl, naphthyl, anthracenyl, phenanthracenyl, biphenyl, and pyrenyl. In some embodiments, the aryl group contains six carbon atoms ("C6 aryl").
[0023] "Alkyl" or "alkyl group," as used herein, includes straight-chain, branched, and cyclic hydrocarbon chains that are fully saturated. In some embodiments, an alkyl group contains 1 to 8 carbon atoms ("C1-C8 alkyl"). In some embodiments, an alkyl group contains 1 to 6 carbon atoms ("C1-C6 alkyl"). In some embodiments, an alkyl group contains 1 to 3 carbon atoms. In some embodiments, an alkyl group contains 2 to 3 carbon atoms, and in some embodiments, an alkyl group contains 1 to 2 carbon atoms. In some embodiments, the term "alkyl" or "alkyl group" refers to a cycloalkyl group. In some embodiments, a cycloalkyl group contains 3 to 8 carbon atoms ("C3-C8 cycloalkyl"). In some embodiments, a cycloalkyl group contains 3 to 6 carbon atoms ("C3-C6 cycloalkyl"). Non-limiting examples of exemplary alkyl groups include methyl, ethyl, propyl, isopropyl, butyl, cyclopropyl, and cyclohexyl.
[0024] "Alkenyl" or "alkenyl group", as used herein, includes straight, branched and cyclic hydrocarbon chains containing at least one double bond (unsaturated bond).
[0025] "Alkoxy," as used herein, refers to an alkyl group, as defined above, attached to the main carbon chain through an oxygen ("alkoxy") atom.
[0026] As used herein, "cyclic ring" or "ring" refers to a cyclic moiety having one or more closed rings, including, for example, monocyclic, bicyclic, and tricyclic moieties, including bridged and spiro moieties. The number of ring members in a "cyclic ring" or "ring" refers to the total number of atoms forming the one or more closed rings of the cyclic moiety. For example, 8-azabicyclo[3.2.1]octane is an 8-membered ring, and 3-oxa-9-azabicyclo[3.3.1]nonane is a 9-membered ring.
[0027] "Cycloalkyl," as used herein, refers to a cyclic hydrocarbon chain that is fully saturated and is included within the genus of "alkyl" groups.
[0028] "Cycloalkenyl," as used herein, refers to a cyclic hydrocarbon chain containing at least one double bond (unsaturated bond) and is included within the genus of "alkenyl" groups.
[0029] "Halogen" and "haloatom," as used interchangeably herein, refer to fluorine, chlorine, bromine, and iodine.
[0030] "Haloalkyl" refers to an alkyl group substituted with one or more halo atoms (F, Cl, Br, I). For example, "fluoromethyl" refers to a methyl group substituted with one or more fluoro atoms (e.g., monofluoromethyl, difluoromethyl, or trifluoromethyl).
[0031] "Heteroatom" refers to O, S, N, or P.
[0032] "Heteroalkyl," as used herein, includes straight, branched, and cyclic hydrocarbon chains that are fully saturated and contain at least one heteroatom (oxygen, nitrogen, sulfur, or phosphorus) in the chain.
[0033] "Heterocycloalkyl," as used herein, refers to a cyclic hydrocarbon chain that is fully saturated and that contains at least one heteroatom (oxygen, nitrogen, sulfur, or phosphorus) in the chain.
[0034] "Heterocycloalkenyl," as used herein, refers to a cyclic hydrocarbon chain containing at least one double bond (unsaturated bond) and including at least one heteroatom (oxygen, nitrogen, sulfur, or phosphorus) in the chain.
[0035] "Heteroaryl" refers to a cyclic moiety having one or more closed rings, at least one of which has one or more heteroatoms (oxygen, nitrogen, sulfur, or phosphorus), where at least one of the rings is aromatic, and where one or more rings can be independently fused and / or bridged. Non-limiting examples include thiophenyl, triazolyl, pyridinyl, pyrimidinyl, pyridazinyl, and pyrazinyl.
[0036] "Heterocyclyl" or "heterocyclic," as used herein, refers to a monocyclic heterocycle, bicyclic heterocycle, or tricyclic heterocycle containing at least one heteroatom in the ring. The heterocycle can be saturated, unsaturated, aromatic (e.g., heteroaryl), or non-aromatic. In some embodiments, the heterocycle group contains 2 to 10 carbon atoms, 3 to 10 carbon atoms, 2 to 8 carbon atoms, 3 to 8 carbon atoms, 2 to 6 carbon atoms, 3 to 6 carbon atoms, 2 to 4 carbon atoms, 3 to 4 carbon atoms, or 3 carbon atoms. In some embodiments, the heterocycle can be a 3- to 10-membered ring, a 3- to 8-membered ring, a 3- to 6-membered ring, a 3- to 4-membered ring, or a 3-membered ring.
[0037] A monocyclic heterocycle is a 3-, 4-, 5-, 6-, 7-, or 8-membered ring containing at least one heteroatom independently selected from O, N, P, and S. In some embodiments, a heterocycle is a 3- or 4-membered ring containing one heteroatom selected from O, N, P, and S. In some embodiments, a heterocycle is a 5-membered ring containing zero or one double bond and one, two, or three heteroatoms selected from O, N, P, and S. In some embodiments, a heterocycle is a 6-, 7-, or 8-membered ring containing zero, one, or two double bonds and one, two, or three heteroatoms selected from O, N, P, and S. Representative examples of monocyclic heterocycles include, but are not limited to, azetidinyl, azepanyl, aziridinyl, diazepanyl, 1,3-dioxanyl, 1,3-dioxolanyl, dihydropyranyl (including 3,4-dihydro-2H-pyran-6-yl), 1,3-dithiolanyl, 1,3-dithianyl, imidazolinyl, imidazolidinyl, isothiazolinyl, isothiazolidinyl, isoxazolinyl, isoxazolidinyl, morpholinyl, oxadiazolinyl, oxadiazolidinyl yl, oxazolinyl, oxazolidinyl, piperazinyl, piperidinyl, pyranyl, pyrazolinyl, pyrazolidinyl, pyrrolinyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl (including tetrahydro-2H-pyran-4-yl), tetrahydrothienyl, thiadiazolinyl, thiadiazolidinyl, thiazolinyl, thiazolidinyl, thiomorpholinyl, 1,1-dioxidethiomorpholinyl (thiomorpholinesulfone), thiopyranyl, and trithianyl.
[0038] Bicyclic heterocycles of the present disclosure are exemplified by monocyclic heterocycles fused to an aryl group, or monocyclic heterocycles fused to a monocyclic cycloalkyl, or monocyclic heterocycles fused to a monocyclic cycloalkenyl, or monocyclic heterocycles fused to a monocyclic heterocycle. Representative examples of bicyclic heterocycles include, but are not limited to, 3,4-dihydro-2H-pyranyl, 1,3-benzodioxolyl, 1,3-benzodithiolyl, 2,3-dihydro-1,4-benzodioxinyl, 2,3-dihydro-1-benzofuranyl, 2,3-dihydro-1-benzothienyl, 2,3-dihydro-1H-indolyl, and 1,2,3,4-tetrahydroquinolinyl.
[0039] In some embodiments, the bicyclic heterocycle is a spiroheterocycle. As known in the art, a "spiro" heterocycle is a bicyclic moiety in which the rings are connected through only one atom. This connecting atom, also called the spiro atom, is most often a quaternary atom such as carbon or nitrogen. Spiro compounds can be represented by the prefix spiro followed by square brackets containing the number of atoms in the smaller ring (excluding the spiro atom itself) and the number of atoms in the larger ring, separated by a dot. Examples of such compounds include, but are not limited to, 2,6-diazaspiro[3.3]heptane.
[0040] A tricyclic heterocycle is a bicyclic heterocycle fused to an aryl group, or a bicyclic heterocycle fused to a monocyclic cycloalkyl, or a bicyclic heterocycle fused to a monocyclic cycloalkenyl, or a bicyclic heterocycle fused to a monocyclic heterocycle. Representative examples of tricyclic heterocycles include, but are not limited to, 2,3,4,4a,9,9a-hexahydro-1H-carbazolyl, 5a,6,7,8,9,9a-hexahydrodibenzo[b,d]furanyl, and 5a,6,7,8,9,9a-hexahydrodibenzo[b,d]thienyl.
[0041] Heterocyclic groups of the present disclosure are connected to the parent molecular moiety through any substitutable carbon atom or any substitutable nitrogen, oxygen, or sulfur atom contained within the group, and may contain one or two alkylene bridges of 1, 2, 3, or 4 carbon atoms, each connecting two non-adjacent carbon atoms of the group. Examples of such "bridged" heterocyclic groups include, but are not limited to, oxatricyclo[3.3.1.1 3,7 ]decyl(2-oxatricyclo[3.3.1.1 3,7 ]decyl), 2,4-dioxabicyclo[4.2.1]nonyl, oxabicyclo[2.2.1]heptyl (including 2-oxabicyclo[2.2.1]heptyl), and 2,5-diazabicyclo[2.2.1]heptane.
[0042] In the above heteroaryls and heterocycles, the nitrogen or sulfur atoms can be optionally oxidized to various oxidation states. A specific example is the group S(O) 0~2 refers to -S- (sulfide), -S(O)- (sulfoxide), and -SO2- (sulfone), respectively. For convenience, nitrogen, particularly, but not limited to, nitrogen defined as a cyclic aromatic nitrogen, is intended to include the corresponding N-oxide form. Thus, for compounds of the present disclosure having, for example, a pyridyl ring, the corresponding pyridyl-N-oxide is intended to be included as another compound of the present disclosure.
[0043] "Treatment," "treat," or "treating" of cancer refers to reversing, alleviating, and / or slowing the progression of cancer as described herein.
[0044] "Subject," as used herein, means an animal subject, such as a mammalian subject, particularly a human.
[0045] As used herein, the term "pharmaceutically acceptable carrier" refers to a non-toxic carrier, adjuvant, or vehicle that does not destroy the pharmacological activity of the compound with which it is formulated. Pharmaceutically acceptable carriers, adjuvants, or vehicles that may be used in the compositions of this disclosure include, but are not limited to, ion exchangers, alumina, aluminum stearate, lecithin, serum proteins such as human serum albumin, buffer substances such as phosphates, glycine, sorbic acid, potassium sorbate, partial glyceride mixtures of saturated vegetable fatty acids, water, salts, or electrolytes such as protamine sulfate, disodium hydrogen phosphate, potassium hydrogen phosphate, sodium chloride, zinc salts, colloidal silica, magnesium trisilicate, polyvinylpyrrolidone, cellulose-based substances, polyethylene glycol, cyclodextrin, sodium carboxymethylcellulose, polyacrylates, waxes, polyethylene-polyoxypropylene block polymers, polyethylene glycol, and wool fat.
[0046] A "pharmaceutically acceptable salt" is a salt that retains the desired biological activity of the parent compound and does not impart undesired toxicological effects. Examples of such salts are (a) acid addition salts formed with inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, nitric acid, and the like; and salts formed with organic acids such as acetic acid, oxalic acid, tartaric acid, succinic acid, maleic acid, fumaric acid, gluconic acid, citric acid, malic acid, ascorbic acid, benzoic acid, tannic acid, palmitic acid, alginic acid, polyglutamic acid, naphthalenesulfonic acid, methanesulfonic acid, p-toluenesulfonic acid, naphthalenedisulfonic acid, polygalacturonic acid, and the like; and (b) salts formed from anionic elements such as chlorine, bromine, and iodine. See, e.g., Haynes et al., "Commentary: Occurrence of Pharmaceutically Acceptable Anions and Cations in the Cambridge Structural Database," J. Pharmaceutical Sciences, vol. 94, no. 10 (2005), and Berge et al., "Pharmaceutical Salts," J. Pharmaceutical Sciences, vol. 66, no. 1 (1977), which are incorporated herein by reference.
[0047] Unless otherwise indicated, the nomenclature used to describe chemical groups or moieties as used herein follows the convention that the name is read from left to right with the point of attachment to the rest of the molecule being to the right of the name. For example, the group "(C 1~3 Alkoxy)C 1~3 An "alkyl" is attached to the remainder of the molecule at the alkyl end. Further examples include methoxyethyl, where the point of attachment is at the ethyl end, and methylamino, where the point of attachment is at the amine end.
[0048] Unless otherwise indicated, when a chemical group is depicted by its formula or structure with a terminal attachment point designated by "-", it will be understood that the "-" represents the point of attachment.
[0049] As used herein, the term "compound of formula (I): [ka] (In the formula, Ar 1 teeth, [ka] is selected from: Y 1 N and CX 1 Selected from X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, halogen, cyano, and optionally substituted alkoxy; and R 4 is selected from hydrogen and optionally substituted alkyl; Y 2 is CX 2 and N, and Y 3 is NH, or Y 2 is NH, and Y 3 is CX 2 or X 2 is selected from hydrogen and halogen; Ring A is selected from saturated 6-9 membered cyclic rings optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl; R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n -(O) m - Ring B, wherein k is 0 or 1, n is 0 or 1, m is 0 or 1; R 5 is selected from hydrogen and optionally substituted alkyl; R 6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen, and Ring B is optionally substituted aryl; optionally substituted heteroaryl; optionally substituted cycloalkyl; optionally substituted heterocycloalkyl; optionally substituted cycloalkenyl, and optionally substituted heterocycloalkenyl selected from; and R 2 is selected from hydrogen and optionally substituted alkyl and pharmaceutically acceptable salts thereof.
[0050] In some embodiments, R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, chlorine, fluorine, cyano, and optionally substituted alkoxy.
[0051] In some embodiments, R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n - Ring B. In some embodiments, R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n - Ring B, wherein R 6 and R 7 is fluorine.
[0052] In some embodiments, R 2is selected from hydrogen and C1-C3 alkyl.
[0053] In some embodiments, Ring A is selected from piperidinyl and a saturated 7-9 membered bicyclic ring, and Ring A is optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl.
[0054] In some embodiments, Ring A is piperidinyl optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl. In some embodiments, Ring A is selected from piperidinyl optionally substituted with at least one halogen. In some embodiments, Ring A is selected from piperidinyl optionally substituted with at least one hydroxyl. In some embodiments, Ring A is selected from piperidinyl optionally substituted with at least one optionally substituted alkyl.
[0055] In some embodiments, Ring A is selected from a saturated 7-9 membered bicyclic ring optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl. In some embodiments, Ring A is selected from a saturated 7-9 membered bicyclic ring optionally substituted with at least one halogen. In some embodiments, Ring A is selected from a saturated 7-9 membered bicyclic ring optionally substituted with at least one hydroxyl. In some embodiments, Ring A is selected from a saturated 7-9 membered bicyclic ring optionally substituted with at least one optionally substituted alkyl.
[0056] In some embodiments, Ring A is selected from a saturated 7-membered bicyclic ring optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl. In some embodiments, Ring A is selected from a saturated 8-membered bicyclic ring optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl. In some embodiments, Ring A is selected from a saturated 9-membered bicyclic ring optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl.
[0057] In some embodiments, Ring A is selected from piperidinyl, azaspirooctane, azaspirononane, azabicyclooctane, and oxazabicyclononane, and Ring A is optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl.
[0058] In some embodiments, Ring A is selected from piperidinyl optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl. In some embodiments, Ring A is selected from azaspirooctane optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl. In some embodiments, Ring A is selected from azaspirononane optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl. In some embodiments, Ring A is selected from azabicyclooctane optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl. In some embodiments, Ring A is selected from oxazabicyclononane optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl.
[0059] In some embodiments, Ring A is selected from piperidinyl optionally substituted with at least one halogen. In some embodiments, Ring A is selected from piperidinyl optionally substituted with at least one hydroxyl. In some embodiments, Ring A is selected from piperidinyl optionally substituted with at least one optionally substituted alkyl. In some embodiments, Ring A is selected from azaspirooctane optionally substituted with at least one halogen. In some embodiments, Ring A is selected from azaspirooctane optionally substituted with at least one hydroxyl. In some embodiments, Ring A is selected from azaspirooctane optionally substituted with at least one optionally substituted alkyl. In some embodiments, Ring A is selected from azaspirononane optionally substituted with at least one halogen. In some embodiments, Ring A is selected from azaspirononane optionally substituted with at least one hydroxyl. In some embodiments, Ring A is selected from azaspirononane optionally substituted with at least one optionally substituted alkyl. In some embodiments, Ring A is selected from azabicyclooctane optionally substituted with at least one halogen. In some embodiments, Ring A is selected from azabicyclooctane optionally substituted with at least one hydroxyl. In some embodiments, Ring A is selected from azabicyclooctane optionally substituted with at least one optionally substituted alkyl. In some embodiments, Ring A is selected from oxazabicyclononane optionally substituted with at least one halogen. In some embodiments, Ring A is selected from oxazabicyclononane optionally substituted with at least one hydroxyl. In some embodiments, Ring A is selected from oxazabicyclononane optionally substituted with at least one optionally substituted alkyl.
[0060] In some embodiments, Ring B is selected from optionally substituted 5-10 membered aryl, optionally substituted 5-10 membered heteroaryl, optionally substituted 3-10 membered cycloalkyl, optionally substituted 4-10 membered heterocycloalkyl, optionally substituted 6-10 membered cycloalkenyl, and optionally substituted 6-10 membered heterocycloalkenyl. In some embodiments, Ring B is selected from optionally substituted 5-10 membered heteroaryl. In some embodiments, Ring B is selected from optionally substituted 3-10 membered cycloalkyl. In some embodiments, Ring B is selected from optionally substituted 4-10 membered heterocycloalkyl. In some embodiments, Ring B is selected from optionally substituted 6-10 membered cycloalkenyl. In some embodiments, Ring B is selected from optionally substituted 6-10 membered heterocycloalkenyl.
[0061] In some embodiments, Ring B is selected from an optionally substituted 5-6 membered monocyclic aryl, an optionally substituted 10 membered bicyclic aryl, an optionally substituted 5-6 membered monocyclic heteroaryl, an optionally substituted 9-10 membered bicyclic heteroaryl, an optionally substituted 3-10 membered monocyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered spirocyclic bicyclic alkyl, an optionally substituted 4-10 membered monocyclic heterocycloalkyl, an optionally substituted 7-10 membered bridged bicyclic heterocycloalkyl, an optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyl, an optionally substituted 5-6 membered monocyclic cycloalkenyl, an optionally substituted 8-10 membered bicyclic cycloalkenyl, an optionally substituted 5-6 membered monocyclic heterocycloalkenyl, and an optionally substituted 8-10 membered bicyclic heterocycloalkenyl.
[0062] In some embodiments, Ring B is selected from an optionally substituted 5-6 membered monocyclic aryl. In some embodiments, Ring B is selected from an optionally substituted 10 membered bicyclic aryl. In some embodiments, Ring B is selected from an optionally substituted 5-6 membered monocyclic heteroaryl. In some embodiments, Ring B is selected from an optionally substituted 9-10 membered bicyclic heteroaryl. In some embodiments, Ring B is selected from an optionally substituted 3-10 membered monocyclic alkyl. In some embodiments, Ring B is selected from an optionally substituted 7-10 membered bridged bicyclic alkyl. In some embodiments, Ring B is selected from an optionally substituted 7-10 membered spirocyclic bicyclic alkyl. In some embodiments, Ring B is selected from an optionally substituted 4-10 membered monocyclic heterocycloalkyl. In some embodiments, Ring B is selected from an optionally substituted 7-10 membered bridged bicyclic heterocycloalkyl. In some embodiments, Ring B is selected from optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyl. In some embodiments, Ring B is selected from optionally substituted 5-6 membered monocyclic cycloalkenyl. In some embodiments, Ring B is selected from optionally substituted 8-10 membered bicyclic cycloalkenyl. In some embodiments, Ring B is selected from optionally substituted 5-6 membered monocyclic heterocycloalkenyl. In some embodiments, Ring B is selected from optionally substituted 8-10 membered bicyclic heterocycloalkenyl.
[0063] In some embodiments, Ring B is selected from an optionally substituted 5-6 membered monocyclic aryl, an optionally substituted 10 membered bicyclic aryl, an optionally substituted 5-6 membered monocyclic heteroaryl having 1-3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 9-10 membered bicyclic heteroaryl having 1-3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 3-10 membered monocyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered spirocyclic bicyclic alkyl, an optionally substituted 4-10 membered monocyclic heterocyclo having 1-3 ring heteroatoms selected from oxygen, silicon, and nitrogen. optionally substituted 7- to 10-membered bridged bicyclic heterocycloalkyl having 1 to 3 ring heteroatoms selected from alkyl, oxygen, and nitrogen; optionally substituted 7- to 10-membered spirocyclic bicyclic heterocycloalkyl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen; optionally substituted 5- to 6-membered monocyclic cycloalkenyl; optionally substituted 8- to 10-membered bicyclic cycloalkenyl; optionally substituted 5- to 6-membered monocyclic heterocycloalkenyl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen; and optionally substituted 8- to 10-membered bicyclic heterocycloalkenyl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen.
[0064] In some embodiments, Ring B is selected from optionally substituted 5-6 membered monocyclic aryls.
[0065] In some embodiments, Ring B is selected from optionally substituted 10-membered bicyclic aryls.
[0066] In some embodiments, Ring B is selected from optionally substituted 5-6 membered monocyclic heteroaryls having 1-3 ring heteroatoms selected from oxygen and nitrogen.
[0067] In some embodiments, Ring B is selected from optionally substituted 9-10 membered bicyclic heteroaryls having 1-3 ring heteroatoms selected from oxygen and nitrogen.
[0068] In some embodiments, Ring B is selected from optionally substituted 3-10 membered monocyclic alkyls.
[0069] In some embodiments, Ring B is selected from optionally substituted 7-10 membered bridged bicyclic alkyls.
[0070] In some embodiments, Ring B is selected from optionally substituted 7-10 membered spirocyclic bicyclic alkyls.
[0071] In some embodiments, Ring B is selected from optionally substituted 4-10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon, and nitrogen.
[0072] In some embodiments, Ring B is selected from optionally substituted 7-10 membered bridged bicyclic heterocycloalkyls having 1-3 ring heteroatoms selected from oxygen and nitrogen.
[0073] In some embodiments, Ring B is selected from optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyls having 1-3 ring heteroatoms selected from oxygen and nitrogen.
[0074] In some embodiments, Ring B is selected from optionally substituted 5-6 membered monocyclic cycloalkenyls.
[0075] In some embodiments, Ring B is selected from optionally substituted 8-10 membered bicyclic cycloalkenyls.
[0076] In some embodiments, Ring B is selected from optionally substituted 5-6 membered monocyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen.
[0077] In some embodiments, Ring B is selected from optionally substituted 8-10 membered bicyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen.
[0078] In some embodiments, ring A is [ka] wherein q is 0 or 1; and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl.
[0079] In some embodiments, R 8 and R 9 At least one of the rings A is [ka] and spiro-linked oxetanes such as selected from:
[0080] In some embodiments, disclosed herein are compounds of formulas (II)-(V). [ka] During the ceremony, Y 1 N and CX 1 Selected from X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; Y 2 is CX 2 and N, and Y 3is NH or Y 2 is NH, and Y 3 is CX 2 Either X 2 is selected from hydrogen and halogen; q is 0 or 1; R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n -(O) m - Ring B, wherein k is 0 or 1, n is 0 or 1, and m is 0 or 1; R 5 is selected from hydrogen and optionally substituted alkyl; R 6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen; and Ring B is an optionally substituted 5- to 6-membered monocyclic aryl, an optionally substituted 10-membered bicyclic aryl, an optionally substituted 5- to 6-membered monocyclic heteroaryl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 9- to 10-membered bicyclic heteroaryl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 3- to 10-membered monocyclic alkyl, an optionally substituted 7- to 10-membered bridged bicyclic alkyl, an optionally substituted 7- to 10-membered spirocyclic bicyclic alkyl, an optionally substituted 4- to 10-membered monocyclic heterocycloalkyl having 1 to 3 ring heteroatoms selected from oxygen, silicon, and nitrogen, an acid optionally substituted 7-10-membered bridged bicyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 7-10-membered spirocyclic bicyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 5-6-membered monocyclic cycloalkenyl, optionally substituted 8-10-membered bicyclic cycloalkenyl, optionally substituted 5-6-membered monocyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, and optionally substituted 8-10-membered bicyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen; R 2 is selected from hydrogen and optionally substituted alkyl; R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, halogen, cyano, and optionally substituted alkoxy; R 4 is selected from hydrogen and alkyl; and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl.
[0081] In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC activity of less than 1000 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value of less than 500 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value of less than 250 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value in the range of 0.1 nM to 1000 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value in the range of 0.1 nM to 500 nM. 50 In some embodiments, the compounds of formula (I) and pharmaceutically acceptable salts thereof have a TR-FRET inverse agonist AC value in the range of 0.1 nM to 250 nM. 50 It has a value.
[0082] In some embodiments, R 8 and R 9 At least one of the groups is a spiro-linked oxetane.
[0083] In some embodiments, R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, chlorine, fluorine, cyano, and optionally substituted alkoxy.
[0084] In some embodiments, R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n - Ring B. In some embodiments, R 1 is -(CHR 5 ) k -(CR 6 R7 ) n - Ring B, wherein R 6 and R 7 is fluorine.
[0085] In some embodiments, R 2 is selected from hydrogen and C1-C3 alkyl.
[0086] In some embodiments, ring B is [ka] is selected from: w is 0 or 1; Y 4 and Y 5 are each independently selected from optionally substituted —(CH)—, optionally substituted —(NH)—, and —O—; Y 6 is selected from optionally substituted —(CH)—, optionally substituted —(NH)—, tetraalkylsilane, and —O—; R 10 is selected from hydrogen, halogen, optionally substituted alkyl and carbonyl; and R 11 , R 12 and R 13 are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
[0087] In some embodiments, ring B is [ka] is selected from: R 11 and R 12are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; R 14 is selected from hydrogen and optionally substituted alkyl; R is selected from hydrogen, optionally substituted alkyl and aryl; and R' is selected from hydrogen, optionally substituted alkyl and halogen.
[0088] In some embodiments, ring B is [ka] wherein R 11 , R 12 and R 13 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted amine, and optionally substituted alkoxy.
[0089] In some embodiments, ring B is [ka] is selected from: w is 0 or 1; Y 4 is selected from SO2, optionally substituted sulfonamide, optionally substituted amide, optionally substituted -(CH2)-, optionally substituted -(NH)-, and -O-; R 11 and R 12 are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; and Ring C is selected from a 5-membered aromatic ring, a 5-membered heteroaromatic ring containing one or two ring nitrogen atoms, a 6-membered aromatic ring, and a 6-membered heteroaromatic ring containing one or two ring nitrogen atoms.
[0090] In some embodiments, ring B is [ka] is selected from: Y 4 , Y 5 and Y 6 are each independently selected from optionally substituted —(CH)—, optionally substituted —(NH)—, and —O—; R 11 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; and Ring C is selected from a 5-membered aromatic ring, a 5-membered heteroaromatic ring containing one or two ring nitrogen atoms, a 6-membered aromatic ring, and a 6-membered heteroaromatic ring containing one or two ring nitrogen atoms.
[0091] In some embodiments, ring B is [ka] is selected from: R 11 When is not attached to nitrogen, R 11 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 11 is otherwise selected from hydrogen and optionally substituted alkyl; R 12 When is not attached to nitrogen, R 12 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 12 is otherwise selected from hydrogen and optionally substituted alkyl; R 13When is not attached to nitrogen, R 13 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 13 is otherwise selected from hydrogen and optionally substituted alkyl; and R 14 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine and optionally substituted alkoxy.
[0092] In some embodiments, ring B is [ka] is selected from: Y 4 and Y 5 are each independently selected from optionally substituted —(CH)—, optionally substituted —(NH)—, and —O—; and R 11 and R 12 are independently selected from hydrogen, cyano, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, aryl, heteroaryl, and optionally substituted alkoxy.
[0093] In some embodiments, ring B is [ka] wherein R 11 and R 12 are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
[0094] In some embodiments, ring B is [ka] wherein R 11 , R 12 and R 13 are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
[0095] In some embodiments, ring B is [ka] wherein Y is selected from 6 is selected from optionally substituted -(CH)- and optionally substituted -(NH)-; and R 11 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine and optionally substituted alkoxy.
[0096] In some embodiments, ring B is [ka] is selected from: Y 4 is selected from optionally substituted —(CH)—, optionally substituted —(NH)—, and —O—; Y 5 is selected from optionally substituted —(CH)— and N; and R 11 and R 12 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine and optionally substituted alkoxy.
[0097] In some embodiments, ring B is [ka] wherein R 11 and R 12 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine and optionally substituted alkoxy.
[0098] In some embodiments, ring B is [ka] wherein R 11 , R 12 and R 13 are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
[0099] In some embodiments, R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n -(O) m - Ring B, wherein k is 0 or 1, n is 0 or 1, m is 0 or 1, and R 5 is selected from hydrogen and methyl, R 6 is selected from hydrogen and halogen, R 7 is selected from hydrogen and halogen; and R 2 is selected from hydrogen and methyl.
[0100] In some embodiments, disclosed herein are compounds of the following formula: [ka] During the ceremony, Y 1 N and CX 1 Selected from X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; R3 is selected from hydrogen, optionally substituted C1-C3 alkyl, halogen, cyano, and optionally substituted C1-C3 alkoxy; and R 4 is selected from hydrogen and alkyl; Y 4 is CH2, O and NR 11 Selected from; X 3 is selected from hydrogen and halogen; R' is selected from hydrogen and C1-C3 alkyl optionally substituted with at least one halogen; R 11 is selected from hydrogen and C1-C3 alkyl; R 12 is selected from hydrogen, halogen, and C1-C3 alkyl; and R 13 is selected from hydrogen, halogen, C2-C4 alkoxy and C1-C3 alkyl.
[0101] In some embodiments, disclosed herein are compounds of the following formula: [ka] During the ceremony, X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; X 3 is selected from hydrogen and halogen; and R 11 and R 12 are independently selected from hydrogen and C1-C3 alkyl.
[0102] In some embodiments, the substituted alkyl is selected from haloalkyl.
[0103] In some embodiments, the haloalkyl is trifluoromethyl.
[0104] In some embodiments, disclosed herein are compounds of formula (IIB) and formula (IIIB). [ka] During the ceremony, q is 0 or 1; and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl.
[0105] In some embodiments, provided herein are compounds of Formula (I) and pharmaceutically acceptable salts thereof, which have an activity of less than 40,000 nM, e.g., less than 20,000 nM, less than 10,000 nM, less than 1000 nM, less than 100 nM, less than 50 nM, less than 20 nM, less than 10 nM, or less than 5 nM, as measured using a TR-FRET assay disclosed herein.
[0106] Disclosed herein are pharmaceutical compositions comprising at least one entity selected from the compounds of formula (I) and pharmaceutically acceptable salts thereof.
[0107] In some embodiments, the pharmaceutical composition further comprises at least one pharmaceutically acceptable carrier.
[0108] Disclosed herein are methods for treating and / or preventing cancer, comprising administering to a subject in need thereof an effective amount of at least one entity selected from the compound of Formula (I) and its pharmaceutically acceptable salts, and a pharmaceutical composition comprising at least one entity selected from the compound of Formula (I) and its pharmaceutically acceptable salts. In some embodiments, the cancer is selected from bladder cancer, breast cancer, prostate cancer, and / or cancer with an altered RXRα and / or PPARγ pathway. In some embodiments, the cancer is bladder cancer. In some embodiments, the bladder cancer is advanced bladder cancer, luminal bladder cancer, and / or basal bladder cancer. In some embodiments, the cancer is chemotherapy-resistant and / or immunotherapy-resistant cancer.
[0109] Disclosed herein is the use of at least one entity selected from compounds of formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising at least one entity selected from compounds of formula (I) and pharmaceutically acceptable salts thereof, in the treatment and / or prevention of cancer. In some embodiments, the cancer is selected from bladder cancer, breast cancer, prostate cancer, and cancers with altered RXRα and / or PPARγ pathways. In some embodiments, the cancer is bladder cancer. In some embodiments, the bladder cancer is selected from advanced bladder cancer, luminal bladder cancer, and basal bladder cancer. In some embodiments, the cancer is chemotherapy-resistant and / or immunotherapy-resistant cancer.
[0110] As used herein, compounds of formula (I): 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(4-fluoro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-fluorophenyl)ethyl)piperidine-4-carboxamide; N-((1s,4s)-4-(difluoromethyl)cyclohexyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-(difluoromethyl)cyclohexyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; N-(4-methylcyclohexyl)-1-[5-(2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; 1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; N-((1s,4s)-4-ethylcyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-ethylcyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(3-chloropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; 1-[4-chloro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[4-chloro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; N-((1s,4s)-4-(difluoromethyl)cyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-(difluoromethyl)cyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-methylcyclohexyl)piperidine-4-carboxamide; (R)-1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-(3-chlorophenyl)ethyl]piperidine-4-carboxamide; (S)-1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-(3-chlorophenyl)ethyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(imidazo[1,2-a]pyridin-2-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(2-methyl-1,3-dioxan-5-yl)piperidine-4-carboxamide; N-((1H-indol-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,3,6-trifluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,3-dimethyl-1H-pyrazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-chloro-5-fluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-cyanocyclobutyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-methylpyridin-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(isochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,2S)-2-phenylcyclopropyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-hydroxycyclohexyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4,4-dimethyloxetan-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyloxazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrazolo[1,5-a]pyridin-7-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,5-dimethyl-1H-pyrazol-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(4-chlorophenoxy)propan-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3-difluorocyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methoxycyclobutyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-fluoropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(difluoromethyl)phenyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,3-difluorocyclobutyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,2-difluoro-2-phenylethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3,5-trimethylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-(difluoromethoxy)benzyl)piperidine-4-carboxamide; N-(benzo[d]oxazol-6-ylmethyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-fluorophenyl)ethyl)piperidine-4-carboxamide; N-(5-chloro-2-fluorobenzyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,3-difluorobenzyl)piperidine-4-carboxamide; N-(3-chloro-2-fluorobenzyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-fluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,4-dihydro-2H-pyran-2-yl)methyl)piperidine-4-carboxamide; N-(3-chlorobenzyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (1R,3s,5S)-N-(3-chlorobenzyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3r,5S)-N-(3-chlorobenzyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; N-(3-chlorobenzyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(trifluoromethyl)cyclopentyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1,4-dimethylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-(trifluoromethoxy)benzyl)piperidine-4-carboxamide; N-(bicyclo[3.2.1]octan-8-yl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-[(3-chlorophenyl)methyl]-1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-1,2,4-triazole-3-carbonyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-hydroxypiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-3-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-fluoropiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3-difluorocyclopentyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylpyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-3-fluoropiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(trifluoro-15-methyl)pyridin-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyridin-3-yl)methyl)piperidine-4-carboxamide; N-((1H-indazol-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-indol-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(isoquinolin-6-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-oxo-1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(chroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-1,2,3,4-tetrahydroquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indol-3-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylfuran-2-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,6,7,8-tetrahydroisoquinolin-5-yl)piperidine-4-carboxamide; N-((1H-indazol-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-7-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluorochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-phenylpiperidin-4-yl)piperidine-4-carboxamide; N-((2H-benzo[d][1,2,3]triazol-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; N-((3-fluoro-1H-indazol-5-yl)methyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-indazol-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1H-indol-5-yl)methyl)piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-methyl-1H-indazol-5-yl)methyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-isopropyl-1H-pyrazol-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-oxo-1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; N-(5-chloro-2,3-dihydrobenzofuran-3-yl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-c]pyridin-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,5-dimethyltetrahydrofuran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((8-fluoroimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1H-benzo[d]imidazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1,3-dioxan-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-methylimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indazol-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-chloroimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4,4-difluorotetrahydrofuran-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)oxazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(2-fluorophenyl)pyrrolidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-benzo[d]imidazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-5,6,7,8-tetrahydroquinazolin-5-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(difluoromethyl)isoxazol-3-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indazol-6-yl)methyl)piperidine-4-carboxamide; N-((2-oxabicyclo[3.1.1]heptan-1-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-2,2-dioxide-3,4-dihydro-1H-benzo[c][1,2]thiazin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-cyanochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-2-oxo-1,2,5,6,7,8-hexahydroquinolin-5-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,1-dioxide-2,3-dihydrobenzo[b]thiophen-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(difluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(difluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,3-dimethyl-2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-1H-benzo[d]imidazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-oxo-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; (S)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-azaspiro[2.5]octane-7-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-fluoro-3-methylcyclobutyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-methyltetrahydrofuran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; N-((1H-indol-2-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-methylpyridin-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-methoxychroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(4-fluorophenyl)pyrrolidin-3-yl)piperidine-4-carboxamide; N-((1H-pyrrolo[3,2-c]pyridin-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,2-dimethylpiperidine-4-carboxamide; (R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,2-dimethylpiperidine-4-carboxamide; (S)-5-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-5-azaspiro[3.5]nonane-8-carboxamide; (R)-5-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-5-azaspiro[3.5]nonane-8-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)—N-[(3-fluoro-1H-indazol-5-yl)methyl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,6-dimethylpyrazin-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1H-indol-4-yl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-2,3-dihydrobenzofuran-3-yl)piperidine-4-carboxamide; (2S,5R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,5S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,5R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,5S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; N-[(3-chlorophenyl)methyl]-1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; (1R,3S,5S)-N-[(3-chlorophenyl)methyl]-8-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; N-[(3-fluoro-1H-indazol-5-yl)methyl]-1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-ethylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(1H-indol-5-ylmethyl)piperidine-4-carboxamide; N-[(2,3-dimethyl-1H-indol-5-yl)methyl]-1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; (2R,4R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,6-dimethylpiperidine-4-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]nonan-7-yl)piperidine-4-carboxamide; (1R,3s,5S)—N-((3-fluoro-1-methyl-1H-indazol-5-yl)methyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; N-((3,3-dimethylindolin-5-yl)methyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (1R,3s,5S)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-methyl-1H-indazol-5-yl)ethyl)piperidine-4-carboxamide; 9-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-3-oxa-9-azabicyclo[3.3.1]nonane-7-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((3-fluoro-1H-indazol-5-yl)methyl)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)—N-[(2,3-dimethyl-1H-indol-5-yl)methyl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-fluoro-1H-indazol-5-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-fluoro-1H-indazol-5-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl)ethyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl)ethyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-(1,1-dimethylsilinan-4-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methoxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methoxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8r)-2-oxo-1-azaspiro[4.5]decan-8-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8s)-2-oxo-1-azaspiro[4.5]decan-8-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 4-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(R)-1-(2-fluorophenyl)pyrrolidin-3-yl]-4-azaspiro[2.5]octane-7-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-oxaspiro[3.5]nonan-7-yl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (2R,4S,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4S,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4R,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4S,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4S,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4R,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4R,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4R,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (1R,3S,5S)—N-[(3S,6S)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)—N-[(3S,6R)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)—N-[(3R,6S)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)—N-[(3S,6R)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-hydroxy-4-(perfluoroethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(difluoromethyl)-4-methoxycyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(difluoromethyl)-4-methoxycyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((1s,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(2-methoxyethoxy)-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(2-methoxyethoxy)-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-1,2,4-triazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1s,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(4-(5-hydroxy-2-methylpyridin-4-yl)-1H-imidazole-2-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.2]octan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.2]octan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(2,3-dimethylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(6-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(2-ethylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(2-(hydroxymethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(trifluoromethyl)-1-oxaspiro[3.5]nonan-7-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(3,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4S,7r)-1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4R,7s)-1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8r)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8s)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8r)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8s)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5S,8r)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5R,8s)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(2-(dimethylamino)ethoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-(2-hydroxyethoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-(2-hydroxyethoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.1]heptan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.1]heptan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-hydroxybicyclo[1.1.1]pentan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,4S)-4-((S)-2-methoxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,4S)-4-((R)-2-methoxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-4,5,6,7-tetrahydro-2H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-4,5,6,7-tetrahydro-2H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((R)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((R)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((S)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((S)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1r,4R)-N-((R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1s,4S)-N-((R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1r,4S)-N-((S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1s,4R)-N-((S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(oxetan-3-yl)-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(2-aminoethoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-(2,2-difluoropropyl)-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,4S)-4-((S)-2-aminopropoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,4S)-4-((S)-2-hydroxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(8-oxabicyclo[3.2.1]octan-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3R)-3-(3,3-difluoropyrrolidin-1-yl)-2,2-dimethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3S)-3-(3,3-difluoropyrrolidin-1-yl)-2,2-dimethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-3-(trifluoromethyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-3-(trifluoromethyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methylpyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(3-chloropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(3-chloropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-methylpyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)-2-oxabicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2S,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2S,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2R,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2R,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (R)-N-((1r,4R)-4-(1,1-difluoro-2-methoxyethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1s,4S)-4-(1,1-difluoro-2-methoxyethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1R,3S)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1S,3S)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-116-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1S,3R)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1R,3R)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(perfluoroethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-hydroxy-4-(perfluoroethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4S,7r)-3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4R,7s)-3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-(1,1-difluoroethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(1,1-difluoroethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6R,8aR)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6R,8aS)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6S,8aR)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6S,8aS)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(3-chloro-5-fluoropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(3-chloro-5-fluoropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,3R)-3-(3,3-difluoropyrrolidin-1-yl)-2,2,4,4-tetramethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,3S)-3-(3,3-difluoropyrrolidin-1-yl)-2,2,4,4-tetramethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-(2-fluoro-2-methylpropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-(2-fluoro-2-methylpropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-6-methyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-6-methyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-3-methyl-4,5,6,7-tetrahydro-1H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-3-methyl-4,5,6,7-tetrahydro-1H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-7-fluoro-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-7-fluoro-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-methylpyridazin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-chloro-2-methylpyrimidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloropyrazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-methoxypyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(pyridin-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(pyridin-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-cyanopyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(oxetan-3-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(3-cyanoazetidin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-5-(trifluoromethyl)oxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(oxetan-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(oxetan-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methylpyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(1,1-difluoro-3-methoxypropyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-(1,1-difluoro-3-methoxypropyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-amino-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-amino-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3,5-difluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2S,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2R,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2R,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2S,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (S)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2R,4S)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2S,4R)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2S,4S)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2R,4R)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-(4-methylpiperazin-1-yl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5S,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5R,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((1-fluorocyclopropyl)methyl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,2-dimethylpiperidine-4-carboxamide; (R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,2-dimethylpiperidine-4-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-(hydroxymethyl)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-(hydroxymethyl)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(1-(tert-butylsulfinyl)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4S,7r)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4R,7s)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(4-hydroxybicyclo[2.2.2]octan-1-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(4-hydroxybicyclo[2.2.2]octan-1-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4,6-dimethylpyridazin-3-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5-chloropyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,4R)-4-morpholinotetrahydrofuran-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,4S)-4-morpholinotetrahydrofuran-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrazolo[1,5-a]pyridin-7-ylmethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(oxetan-3-yl)piperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-morpholinocyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-morpholinocyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,5S,7r)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,5S,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(methylsulfonyl)piperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(oxetan-3-yl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(oxetan-3-yl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4S)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4S)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4R)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4R)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,6S)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,6R)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,6R)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,6S)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-fluoroethyl)-2,2-dimethylpiperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-fluoroethyl)-2,2-dimethylpiperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4R)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4S)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4R)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-methylpyrimidin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-methylpyrimidin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-(trifluoromethyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((S)-tetrahydrofuran-3-yl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((R)-tetrahydrofuran-3-yl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-((3-chloro-5-(3,5-dimethylpiperazin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)—N-(4-(1,1-difluoro-2-hydroxyethyl)-4-hydroxycyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(4-cyano-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)—N-((1s,4R)-4-(cyanomethyl)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(cyanomethyl)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-(2-fluoro-2-methylpropyl)-2-azabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)—N-(4-amino-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-(2-fluoro-2-methylpropyl)-2-azabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-(trifluoromethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-oxa-5-azaspiro[3.5]nonane-8-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-((R)-1-hydroxyethyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-((S)-1-hydroxyethyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(oxetan-3-yloxy)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-((5-(3,5-dimethylpiperazin-1-yl)pyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-cyanocyclopropyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(2-methoxy-5-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(1H-pyrazolo[3,4-b]pyridin-4-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N—((R)-1-(1H-pyrazolo[3,4-b]pyridin-4-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-6-methylpyrazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(6-methylpyridazin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(6-methylpyridazin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-methylpyrimidin-5-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-methylpyrimidin-5-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-((3-hydroxyoxetan-3-yl)methyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-((3-hydroxyoxetan-3-yl)methyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxypyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-cyanopyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-(3,5-dichloropyridin-2-yl)cyclopropyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(2,2-difluoro-3-hydroxypropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(2,2-difluoro-3-hydroxypropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,4S)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,4R)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-((R)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N—((R)-1-((S)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((R)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((S)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-3-chloropyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-3-chloropyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-((R)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N—((R)-1-((S)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((R)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((S)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,4,5-trimethyl-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-((1S,2S)-2-cyanocyclopropyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-((1R,2R)-2-cyanocyclopropyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluoropyrazolo[1,5-a]pyridin-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluoropyrazolo[1,5-a]pyridin-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,6R)-2,5-diazabicyclo[4.1.0]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,6S)-2,5-diazabicyclo[4.1.0]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-((1-hydroxycyclopropyl)methyl)pyrrolidin-3-yl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-((1-hydroxycyclopropyl)methyl)pyrrolidin-3-yl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyanopyrimidin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyanopyrimidin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3R,4S)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3S,4R)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,3R,4S)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,3S,4R)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((5-(trifluoromethyl)-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(5-(2-acetyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((S)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((S)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((R)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((R)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-cyclopropyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-cyclopropyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-((1S,2S)-2-(hydroxymethyl)cyclopropyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-((1R,2R)-2-(hydroxymethyl)cyclopropyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((2-((3S,5R)-3,5-dimethylpiperazin-1-yl)-5-(trifluoromethyl)oxazol-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-ethyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-ethyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)-2-((3S,5R)-3,4,5-trimethylpiperazin-1-yl)oxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-5-azaspiro[3.5]nonane-8-carboxamide; (R)-5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-5-azaspiro[3.5]nonane-8-carboxamide; (S)—N-(5-cyanopyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(1-(6-cyanopyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyanopyridin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyanopyridin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-(5-methylpyrazin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-(5-methylpyrazin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-isopropoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxy-3-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxy-3-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(6-acetylpyrazolo[1,5-a]pyridin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-((S)-1-hydroxyethyl)pyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-((R)-1-hydroxyethyl)pyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-N-(7',8'-dihydro-6'H-spiro[oxetan-3,5'-quinoline]-8'-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(5-ethyl-2-oxa-5-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5,5-dimethyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1-(aminomethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3R,4S)-3-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3S,4R)-3-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((4-(trifluoromethyl)-1H-imidazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2R,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2S,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2R,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2S,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2R,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2S,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2R,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2S,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)isoxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-cyclopropylpyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-cyclopropylpyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-4-(trifluoromethyl)-1H-pyrazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-5-(trifluoromethyl)-1H-1,2,3-triazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(((S)-3,3-difluoropiperidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(((R)-3,3-difluoropiperidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((5-fluoropyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-5-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-5-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-methyl-4-(trifluoromethyl)thiazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(hydroxymethyl)-3-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(hydroxymethyl)-3-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-(trifluoromethyl)-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(hydroxymethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(4-methylpiperazin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3S)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3S)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3R)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3R)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)pyridin-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxy-3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(6-cyanopyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(6-cyanopyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(2-chloro-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(2-chloro-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxy-3-(trifluoromethyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; and Pharmaceutically acceptable salts thereof are disclosed.
[0111] The synthesis of compounds of Formula (I) and pharmaceutically acceptable salts thereof can be carried out using techniques familiar to those of skill in the art, as described herein, including in the Examples. Synthetic methods for preparing exemplary compounds described herein are described in the Examples. These methods can be used to synthesize compounds of Formula (I) by using reactants appropriate for the preparation of the specific compound using the techniques and methods described herein and routinely practiced in the art. As further examples, Schemes 1-5 provide schematic diagrams of synthetic schemes for exemplary compounds described herein.
[0112] In general, compounds of formula (I) can be prepared according to the following general reaction scheme. [ka]
[0113] In Scheme 1 above, R 1 , R 3 , R 4 , Y 1and ring A are as described herein.
[0114] As illustrated in Scheme 1 above, a pyrazole-3-carboxylic acid of formula 1-a and a compound of formula 1-b are coupled together in a suitable solvent, such as DMF. A suitable coupling reagent, such as EDCI / HOBt, facilitates the reaction in the presence of a suitable base, such as DIPEA or TEA. The reaction can be carried out at room temperature or at an elevated temperature.
[0115] Alkyl esters of formula 1-c are converted to acids of formula 1-d by hydrolysis of the ester group using standard conditions, such as LiOH in a mixture of water, MeOH and THF.
[0116] Compounds of formula 1-f are prepared as a mixture of enantiomers by reaction of an acid of formula 1-d with a reagent containing a primary amine of formula 1-e via a coupling reaction using a coupling reagent such as EDCI / HOBt in the presence of a suitable base and solvent.
[0117] In some embodiments, the compound of formula 1-f is prepared as a mixture of enantiomers by alkylating the pyrazole product from the coupling reaction with SEM-Cl in the presence of a suitable base, such as KCO, in a suitable solvent, such as DMF. In some embodiments, the protected compound of formula 1-f is formed by treatment with DHP in the presence of p-TsOH in THF.
[0118] In some embodiments, pyrazole bromides of formula 1-f are reacted with arylboronic acids 1-g under standard Suzuki coupling conditions known to those skilled in the art to form compounds of formula 1-i as a mixture of enantiomers.
[0119] In some embodiments, the pyrazole bromide of formula 1-f' is first converted to the pyrazole boronic acid of formula 1-f' by reacting with B2Pin2 in 1,4-dioxane in the presence of a palladium reagent, such as Pd(dppf)Cl2, and KOAc at elevated temperature for several hours.
[0120] In some embodiments, pyrazoles of formula 1-f are reacted in an Ir-catalyzed boronation process using Dtbpy, [Ir(COD)OMe], B2Pin2 in MTBE, THF to undergo a C-H boronation process to synthesize compounds of formula 1-f'.
[0121] Compounds of formula 1-f' can then undergo Suzuki coupling reaction with aryl bromides of formula 1-g' under standard conditions to give compounds of formula 1-h.
[0122] Compounds of formula 1-i as a mixture of enantiomers may be prepared by cleavage of the protecting group, such as SEM or THP, using a suitable acid, such as TFA in DCM.
[0123] Enantiomers of compounds of formula 1-i may be separated using a chiral purification column, such as a CHIRALPAK IF column.
[0124] [ka] In Scheme 2 above, R 1 , Y 1 , Y 2 , ring A is as described herein.
[0125] Compounds of formula 2-b can be prepared by hydrolysis of either the free NH or N-protected pyrazole acid of formula 2-a using conditions known to those skilled in the art. Standard conditions, such as LiOH or NaOH in a mixture of MeOH, water, and THF, can be used.
[0126] Compounds of formula 2-d are prepared by coupling of acids of formula 2-b with amines of formula 2-c using standard coupling reagents such as HATU in the presence of a suitable base such as DIPEA in DMF.
[0127] In some embodiments, compounds of formula 2-d containing a free pyrazole NH are further protected with a THP protecting group by reaction of DHP with a suitable acid, for example, p-TsOH in THF.
[0128] Compounds of formula 2-f, including protected pyrazoles, in some embodiments as a mixture of enantiomers, can be prepared by reacting arylboronic acids of formula 2-e with aryl bromides of formula 2-d under standard Suzuki coupling conditions using conditions known to those skilled in the art: standard Suzuki conditions, such as Pd(dppf)Cl, in the presence of a base, such as KCO, in a suitable solvent, such as a mixture of 1,4-dioxane and water.
[0129] In some embodiments, the compound of formula 2-g, as a mixture of enantiomers, can be prepared by cleavage of the protecting group. In some embodiments, the benzyl protecting group is removed using a catalytic amount of palladium in the presence of ammonium formate. In some embodiments, the THP protecting group is removed by using a suitable acid, such as HCl in MeOH or TFA in DCM.
[0130] [ka] In Scheme 3 above, R 1 , R 2 , R 3 , and Y 1 is as described herein.
[0131] Compounds of formula 3-c can be prepared by coupling a commercially available acid of formula 3-a with an alkyl ester piperidine of formula 3-b using standard coupling conditions with a reagent such as HATU or EDCI / HOBt in the presence of a suitable base such as DIPEA in DMF. In some embodiments, compounds of formula 3-c are protected with a THP or SEM protecting group under suitable conditions known to those skilled in the art to produce aryl bromides of formula 3-d. Compounds of formula 3-d are further reacted with aryl boronic acids of formula 3-e using a Suzuki coupling reaction to produce biaryl compounds of formula 3-f.
[0132] In some embodiments, compounds of formula 3-c are protected with the THP protecting group using DHP in the presence of p-TsOH. This product can be further reacted using Ir-catalyzed boronation using Dtbpy, [Ir(COD)OMe]2, B2Pin2 in MTBE and THF to synthesize compounds of formula 3-d'. Compounds of formula 3-d' can be reacted with arylboronic acids of formula 3-e' in a Suzuki coupling reaction to generate compounds of formula 3-f.
[0133] In some embodiments, the compound of formula 3-f is first treated with TFA in DCM or other suitable conditions to deprotect the THP group.
[0134] In some embodiments, compounds of formula 3-g are prepared by hydrolysis of the ester of compound 3-f or deprotected 3-f using standard hydrolysis conditions, such as hydrolysis of t-butyl esters with TFA in DCM and hydrolysis of methyl esters with LiOH in a mixture of THF, MeOH, and water.
[0135] The acid of formula 3-g can be coupled with an amine of formula 3-h using conditions such as T3P®, HATU, or EDCI / HOBt in the presence of a suitable base, such as TEA or DIPEA, in a solvent such as DMF. In some embodiments, the acid of formula 3-g is converted to its corresponding acyl chloride using a reagent such as oxalyl chloride in DMF and DCM, followed by the addition of an amine of formula 3-h with DIPEA and DMAP. The THP protecting group in the product of this coupling reaction is cleaved using, for example, TFA in DCM to produce a compound of formula 3-i. In some embodiments, the diastereomers of compound 3-i were further separated using chiral separation.
[0136] [ka] In Scheme 4 above, R 1 , R 3 , Y 1 , Y 2 , Y 3 and ring A are as described herein.
[0137] As illustrated in Scheme 4 above, compounds of formula 4-c can be prepared by coupling acids of formula 4-a with amines of formula 4-b using coupling conditions such as, but not limited to, HATU or EDCI / HOBt, DIPEA in DMF.
[0138] Compounds of formula 4-d can be prepared by deprotection of the t-Boc protecting group using suitable conditions such as TFA in DCM or HCl in 1,4-dioxane.
[0139] Compounds of formula 4-f can be prepared by adding a protecting group such as SEM or THP to compounds of formula 4-e using standard conditions known to those skilled in the art, such as SEM-Cl in the presence of K2CO3 or NaH in DMF or DHP in the presence of p-TsOH in THF.
[0140] In some embodiments, a compound of formula 4-f is reacted with a boronic acid of formula 4-g using standard Suzuki coupling conditions to produce a compound of formula 4-h. Suzuki conditions may use a reagent such as Pd(dppf)Cl2 with a base such as K2CO3 or K3PO4 in a suitable solvent such as 1,4-dioxane or water. In some embodiments, the product of the Suzuki coupling is subjected to SEM or THP deprotection to form a product of formula 4-h.
[0141] Alternatively, in some embodiments, compounds of formula 4-f are converted to boronic acids 4-f' using boronation conditions such as Dtbpy, [Ir(Cod)OMe]2, or B2pin2 in MTBE. Compounds of formula 4-h can then be prepared using standard Suzuki coupling conditions between compounds of formula 4-f' and 4-g'.
[0142] Compounds of formula 4-h can be hydrolyzed using standard conditions, such as LiOH in a mixture of water, THF, and MeOH, to provide acids of formula 4-i. In some embodiments, the product formed by hydrolysis can be deprotected of the SEM or THP groups to produce unprotected compounds 4-i.
[0143] Compounds of formula 4-j can be prepared by an amide coupling reaction between compounds of formula 4-i and formula 4-d using conditions such as EDCI / HOBt or HATU with DIPEA in DMF. In some embodiments, compounds of formula 4-j are prepared by the direct reaction of an ester of formula 4-h with an amine of formula 4-d promoted by a reagent such as AlMe3.
[0144] In some embodiments, cleaving a protecting group, such as SEM, from a compound of formula 4-j produces a compound of formula 4-k. In some embodiments, a diastereomeric mixture of compounds of formula 4-k is separated using chiral separation techniques.
[0145] [ka] In Scheme 5 above, R 1 , Ar 1 and ring A are as described herein.
[0146] As illustrated in Scheme 5 above, a compound of formula 5-a can be protected with a suitable protecting group, such as SEM or THP. In some embodiments, a compound of formula 5-b is reacted with an arylboronic acid of formula 5-c under standard Suzuki coupling conditions. Standard Suzuki reaction conditions include, for example, a catalytic palladium source, such as Pd(dppf)Cl, in the presence of a suitable base, such as KCO, in a solvent, such as water or 1,4-dioxane. The reaction can be carried out at ambient or elevated temperature.
[0147] In some embodiments, compounds of formula 5-b undergo a C-H boronation reaction using Dtbpy, [Ir(Cod)OMe], and B2Pin2 in MTBE to form boronic acids of formula 5-b'. Compounds of formula 5-b' can then be reacted with aryl halides of formula 5-c' under standard Suzuki reaction conditions.
[0148] In some embodiments, the compound of formula 5-d is subjected to a deprotection reaction under suitable conditions, for example, with TFA in DCM.
[0149] Alkyl esters of formula 5-e can be hydrolyzed using standard conditions such as LiOH in a mixture of THF, MeOH, and water.
[0150] The acid of formula 5-f and the alkylamine of formula 5-g can be coupled together using a suitable coupling reagent, such as HATU or HOBt / EDCI, in the presence of a suitable base, such as DIPEA, to promote the reaction. A suitable solvent, such as DMF, can be used.
[0151] In some embodiments, the enantiomeric mixture of alkyl esters of formula 5-h is separated by chiral column purification. In some embodiments, this mixture is used in the next step without prior separation. Compounds of formula 5-h can be hydrolyzed to acids of formula 5-i using LiOH in a mixture of THF, MeOH, and water, or, in the case of tert-butyl esters, using HCl in 1,4-dioxane.
[0152] Acids of formula 5-i can be coupled with amines of formula 5-j using standard amide coupling conditions, such as HATU or HOBt / EDCI, DIPEA in DMF, etc. In some embodiments, compounds of formula 5-j can be deprotected to produce compounds of formula 5-k. In some embodiments, when compounds of formula 5-k exist as a diastereomeric mixture, the diastereomers are separated by purification on a chiral column.
[0153] It will be understood that further synthetic manipulations may be desired to obtain certain compounds of formula (I). Variations of the above general reaction scheme I are possible, such as changing one or more starting materials or modifying any of the reaction products. Methods for these and other variations of the above exemplary schemes are well known in the art and are described in further detail in the Examples.
[0154] Those skilled in the art will also understand that in the processes described herein, functional groups of intermediate compounds, even if not specifically mentioned, may need to be protected by suitable protecting groups. Such functional groups include hydroxy, amino, mercapto, and carboxylic acid. Suitable protecting groups for hydroxy include trialkylsilyl or diarylalkylsilyl (e.g., t-butyldimethylsilyl, t-butyldiphenylsilyl, or trimethylsilyl), tetrahydropyranyl, benzyl, and the like. Suitable protecting groups for amino, amidino, and guanidino include t-butoxycarbonyl, benzyloxycarbonyl, and the like. Suitable protecting groups for mercapto include C(O)R″ (where R″ is alkyl, aryl, or arylalkyl), p-methoxybenzyl, trityl, and the like. Suitable protecting groups for carboxylic acid include alkyl, aryl, or arylalkyl esters. Protecting groups can be added or removed according to standard techniques known to those skilled in the art and as described herein. The use of protecting groups is described in detail in Green, T. W. and P. G. M. Hutz, Protective Groups in Organic Synthesis (1999), 3rd Ed., Wiley. As will be appreciated by those skilled in the art, the protecting group can also be a polymeric resin such as a Wang resin, a Rink resin, or a 2-chlorotrityl chloride resin.
[0155] Reactants similar to those described above can be identified in the index of known chemicals produced by the Chemical Abstract Service of the American Chemical Society, which is available in most public and university libraries and online databases (further details can be contacted from the American Chemical Society, Washington, DC). Chemicals that are known but not commercially available in catalogs can be prepared by chemical synthesis companies that undertake custom orders, where many of the standard chemical supply companies (e.g., those listed above) offer custom synthesis services. A reference for the preparation and selection of pharmaceutical salts of this disclosure is P.H. Stahl & C.G. Wermuth, "Handbook of Pharmaceutical Salts," Verlag Helvetica Chimica Acta, Zurich, 2002.
[0156] In general, the compounds used in the reactions described herein can be made according to General Reaction Schemes 1-5 and / or organic synthesis techniques known to those skilled in the art, starting from commercially available chemicals and / or compounds described in the chemical literature."Commercial Chemicals" means Acros Organics (Pittsburgh PA), Aldrich Chemical (Milwaukee WI, including Sigma Chemical and Fluka), Apin Chemicals Ltd. (Milton Park UK), Avocado Research (Lancashire UK), BDH Inc. (Toronto, Canada), Bionet (Cornwall, UK), Chemservice Inc. (West Chester PA), Crescent Chemical Co. (Hauppauge). NY), Eastman Organic Chemicals, Eastman Kodak Company(Rochester NY), Fisher Scientific Co.(Pittsburgh PA), Fisons Chemicals(Leicestershire UK), Frontier Scientific(Logan UT), ICN Biomedicals, Inc.(Costa Mesa CA), Key Organics(Cornwall UK), Lancaster Synthesis(Windham NH), Maybridge Chemical Co.Ltd.(Cornwall UK), Parish Chemical Co. (Orem (Rockville, VA), TCI America (Portland, OR), Trans World Chemicals, Inc. (Rockville, MD), and Wako Chemicals USA, Inc. (Richmond, VA).
[0157] Methods known to those skilled in the art can be identified in various reference books, articles, and databases. Suitable reference books and monographs detailing the synthesis of reactants useful in preparing the compounds of the present disclosure or providing references to articles describing the preparation include, for example, "Synthetic Organic Chemistry," John Wiley & Sons, Inc., New York; S.R. Sandler et al., "Organic Functional Group Preparations," 2nd Ed., Academic Press, New York, 1983; H.O. House, "Modern Synthetic Reactions," 2nd Ed., W.A. Benjamin, Inc., Menlo Park, Calif., 1972; T.L.G. Gilchrist, "(Heterocyclic Chemistry), 2nd Ed., John Wiley & Sons, New York, 1992; J. March, "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure," 4th Ed., Wiley-Interscience, New York, 1994. New York, 1992. Additional suitable reference books and monographs detailing the synthesis of or providing references to articles describing the preparation of reactants useful in preparing the compounds of the present disclosure include, for example, Fuhrhop, J. and Penzlin G. "Organic Synthesis: Concepts, Methods, Starting Materials", Second, Revised and Enlarged Edition (1994) John Wiley & Sons, ISBN: 3 527-29074-5; Hoffman, RV "Organic Chemistry, An Intermediate Text" (1996) Oxford University Press, ISBN 0-19-509618-5; Larock, RC“Comprehensive Organic Transformations: A Guide to Functional Group Preparations” 2nd Edition (1999) Wiley-VCH, ISBN: 0-471-19031-4; March, J. “Advanced Organic Chemistry: Reactions, Mechanisms, and Structure” 4th Edition (1992) John Wiley & Sons, ISBN: 0-471-60180-2; Otera, J. (editor) “Modern Carbonyl Chemistry” (2000) Wiley-VCH, ISBN: 3-527-29871-1; Patai, S. “Patai’s 1992 Guide to the Chemistry of Functional Groups” (1992) Interscience ISBN: 0-471-93022-9; Quin, L. D. et al. “A Guide to Organophosphorus Chemistry” (2000) Wiley-Interscience, ISBN: 0-471-31824-8; Solomons, T. W. G. “Organic Chemistry” 7th Edition (2000) John Wiley & Sons, ISBN: 0-471-
[0158] Disclosed herein are compositions comprising at least one entity selected from compounds of formula (I) and pharmaceutically acceptable salts thereof, and optionally at least one pharmaceutically acceptable carrier. The at least one pharmaceutically acceptable carrier may be selected according to the particular route of administration for which the composition is intended.
[0159] The pharmaceutical compositions of the present disclosure may be formulated for parenteral, oral, inhalation spray, topical, rectal, nasal, buccal, vaginal, and / or implanted reservoir administration, etc. The term "parenteral" as used herein includes subcutaneous, intravenous, intramuscular, intra-articular, intrasynovial, intrasternal, intrathecal, intrahepatic, intralesional, and intracranial injection or infusion techniques. In some embodiments, the compositions are administered intravenously, orally, subcutaneously, or intramuscularly. Sterile injectable compositions of the present disclosure may be aqueous or oily suspensions. Such suspensions may be formulated according to techniques known in the art using suitable dispersing or wetting agents and suspending agents. The sterile injectable preparation may also be a sterile injectable solution or suspension in a non-toxic parenterally acceptable diluent or solvent, for example, as a solution in 1,3-butanediol. Among the acceptable vehicles and solvents that may be employed are water, Ringer's solution, and isotonic saline. In addition, sterile, fixed oils are conventionally employed as solvents or suspending media.
[0160] Any non-irritating fixed oil can be used, including synthetic mono- or diglycerides. Fatty acids, such as oleic acid and its glyceride derivatives, are useful in the preparation of injections, as are natural pharmaceutically acceptable oils, such as olive oil or castor oil, especially their polyoxyethylated versions. These oil solutions or suspensions can also contain long-chain alcohol diluents or dispersants, such as carboxymethylcellulose, or similar dispersants commonly used in the formulation of pharmaceutically acceptable dosage forms, including emulsions and suspensions. Other commonly used surfactants, such as Tween, Span, and other emulsifiers or bioavailability enhancers commonly used in the manufacture of pharmaceutically acceptable solid, liquid, or other dosage forms, can also be used for formulation.
[0161] For oral administration, the compound (e.g., a compound of Formula (I) or a pharmaceutically acceptable salt thereof) may be provided in an acceptable oral dosage form, including, but not limited to, a capsule, a tablet, an aqueous suspension, or a solution. In the case of tablets for oral use, commonly used carriers include lactose and cornstarch. Lubricants such as magnesium stearate may also be added. For oral administration in capsule form, useful diluents include lactose and dried cornstarch. When aqueous suspensions are required for oral use, the active ingredient is combined with an emulsifying agent and / or suspending agent. If necessary, certain sweetening, flavoring, or coloring agents may also be added.
[0162] The compounds and compositions of the present disclosure can be used to treat and / or prevent various cancers, including cancers that respond to drugs targeting the RXRα and / or PPARγ pathways. Thus, disclosed herein is a method for treating and / or preventing cancer, comprising administering to a subject in need thereof an effective amount of at least one entity selected from the group consisting of compounds of Formula (I) and pharmaceutically acceptable salts thereof. In some embodiments, the cancer is selected from advanced bladder cancer, luminal breast cancer, prostate cancer, luminal bladder cancer, basal bladder cancer, chemotherapy-resistant cancer, and immunotherapy-resistant cancer.
[0163] In general, appropriate dosages and treatment regimens provide at least one compound of the present disclosure in an amount sufficient to provide a therapeutic and / or prophylactic benefit. For both therapeutic treatments and prophylactic or preventative measures, therapeutic and / or prophylactic benefit includes, for example, improved clinical outcomes, where the objective is to prevent, slow or delay (lessen) an undesirable physiological change or disorder, or to prevent, slow or delay (lessen) the progression or severity of such a disorder. As discussed herein, beneficial or desired clinical results of treating a subject include, but are not limited to, amelioration, reduction, or alleviation of symptoms caused by or associated with the disease, condition, or disorder being treated; a reduction in the incidence of symptoms; an improvement in quality of life; a prolonged disease-free state (i.e., a reduction in the likelihood or propensity of a subject to exhibit symptoms that provide a basis for diagnosing the disease); a reduction in the extent of the disease; a stabilization of the disease state (i.e., not worsening); a delay or slowing of disease progression; an improvement or palliative of the disease state; and remission (whether partial or complete), whether detectable or undetectable, and / or overall survival. "Treatment" can also include extending survival compared to the subject's expected survival if they had not received treatment. Subjects in need of treatment include (i) those already suffering from a cancer that responds to drugs targeting, for example, the RXRα and / or PPARγ pathways; (ii) those susceptible to or at risk of developing such cancer; and (iii) those in whom such cancer should be prevented (i.e., reducing the likelihood of the disease, disorder, or condition occurring).
[0164] In some embodiments of the methods described herein, the subject is a human. In some embodiments of the methods described herein, the subject is a non-human animal. A subject in need of treatment as described herein may exhibit at least one symptom or sequela of such cancer or may be at risk of developing such cancer. Non-human animals that can be treated include mammals, such as non-human primates (e.g., monkeys, chimpanzees, gorillas, etc.), rodents (e.g., rats, mice, gerbils, hamsters, ferrets, rabbits), lagomorphs, swine (e.g., pigs, minipigs), equines, canines, felines, bovines, and other domestic, farm, and zoo animals.
[0165] The effectiveness of the compounds of the present disclosure in treating and / or preventing cancers that respond to drugs targeting the RXRα and / or PPARγ pathways can be easily determined by those skilled in the medical and clinical fields. Determining and adjusting an appropriate dosage regimen (e.g., adjusting the amount of compound per dose and / or the number of doses and the frequency of dose administration) can also be easily performed by those skilled in the medical and clinical fields. The health status of a subject can be monitored using one or any combination of diagnostic methods, including physical examination, determining and monitoring clinical symptoms, and performing the analytical tests and methods described herein.
[0166] The administration of at least one entity of the present disclosure or a pharmaceutical composition comprising at least one such entity may be in combination with one or more other therapies, such as at least one additional anti-cancer agent or at least one agent that reduces the toxicity of the therapy. For example, at least one palliative may be administered that counteracts (at least partially) the side effects of the therapy. Agents (chemical or biological) that promote recovery or counteract the side effects of administering antibiotics or corticosteroid drugs are examples of such palliatives.
[0167] Additional embodiments include the following:
[0168] 1. Formula (I) [ka] (In the formula, Ar 1 teeth, [ka] is selected from: Y 1 N and CX 1 Selected from X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, halogen, cyano, and optionally substituted alkoxy; and R 4 is selected from hydrogen and alkyl; Y 2 is CX 2 and N, and Y 3 is NH or Y 2 is NH, and Y 3 is CX 2 or X 2 is selected from hydrogen and halogen; Ring A is selected from saturated 6-9 membered cyclic rings optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl; R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n -(O) m - Ring B, wherein k is 0 or 1, n is 0 or 1, m is 0 or 1; R 5 is selected from hydrogen and optionally substituted alkyl; R6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen, and Ring B is optionally substituted aryl; optionally substituted heteroaryl; optionally substituted cycloalkyl; optionally substituted heterocycloalkyl; optionally substituted cycloalkenyl, and optionally substituted heterocycloalkenyl selected from; and R 2 is selected from hydrogen and optionally substituted alkyl or a pharmaceutically acceptable salt thereof.
[0169] 2. The compound or pharmaceutically acceptable salt of embodiment 1, wherein ring A is selected from piperidinyl and a saturated 7-9 membered bicyclic ring, and ring A is optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl.
[0170] 3. The compound or pharmaceutically acceptable salt of embodiment 1 or 2, wherein Ring A is selected from piperidinyl, azaspirooctane, azaspirononane, azabicyclooctane, and oxazabicyclononane, and Ring A is optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl.
[0171] 4. Ring B is optionally substituted 5- to 10-membered aryl; optionally substituted 5-10 membered heteroaryl; optionally substituted 3- to 10-membered cycloalkyl; optionally substituted 4- to 10-membered heterocycloalkyl; optionally substituted 6- to 10-membered cycloalkenyl, and optionally substituted 6- to 10-membered heterocycloalkenyl 4. The compound of any one of embodiments 1 to 3, or a pharmaceutically acceptable salt thereof, selected from:
[0172] 5. Ring B is an optionally substituted 5-6 membered monocyclic aryl, an optionally substituted 10 membered bicyclic aryl, an optionally substituted 5-6 membered monocyclic heteroaryl, an optionally substituted 9-10 membered bicyclic heteroaryl, an optionally substituted 3-10 membered monocyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered spirocyclic bicyclic alkyl, an optionally substituted 4-10 membered monocyclic heterocycloalkyl, optionally The compound or pharmaceutically acceptable salt of any one of embodiments 1-4, wherein the compound is selected from substituted 7-10 membered bridged bicyclic heterocycloalkyl, optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyl, optionally substituted 5-6 membered monocyclic cycloalkenyl, optionally substituted 8-10 membered bicyclic cycloalkenyl, optionally substituted 5-6 membered monocyclic heterocycloalkenyl, and optionally substituted 8-10 membered bicyclic heterocycloalkenyl.
[0173] 6. Ring B is an optionally substituted 5- to 6-membered monocyclic aryl, an optionally substituted 10-membered bicyclic aryl, an optionally substituted 5- to 6-membered monocyclic heteroaryl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 9- to 10-membered bicyclic heteroaryl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 3- to 10-membered monocyclic alkyl, an optionally substituted 7- to 10-membered bridged bicyclic alkyl, an optionally substituted 7- to 10-membered spirocyclic bicyclic alkyl, an optionally substituted 4- to 10-membered monocyclic heterocycloalkyl having 1 to 3 ring heteroatoms selected from oxygen, silicon, and nitrogen, an optionally substituted 4- to 10-membered monocyclic heterocycloalkyl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen. optionally substituted 7-10 membered bridged bicyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 5-6 membered monocyclic cycloalkenyl, optionally substituted 8-10 membered bicyclic cycloalkenyl, optionally substituted 5-6 membered monocyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, and optionally substituted 8-10 membered bicyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen.
[0174] 7. Ring A is [ka] wherein q is 0 or 1, and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl. 7. The compound of any one of embodiments 1 to 6, or a pharmaceutically acceptable salt thereof, selected from:
[0175] 8. Formulas (II)~(V): [ka] (In the formula, Y 1 N and CX 1 Selected from X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; R 2 is selected from hydrogen and optionally substituted alkyl; R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, halogen, cyano, and optionally substituted alkoxy; R 4 is selected from hydrogen and alkyl; Y 2 is CX 2 and N, and Y 3 is NH, or Y 2 is NH, and Y 3 is CX 2 or X 2 is selected from hydrogen and halogen; q is 0 or 1; R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n -(O) m - Ring B, wherein k is 0 or 1, n is 0 or 1, m is 0 or 1; R 5 is selected from hydrogen and optionally substituted alkyl; R 6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen, and Ring B is an optionally substituted 5- to 6-membered monocyclic aryl, an optionally substituted 10-membered bicyclic aryl, an optionally substituted 5- to 6-membered monocyclic heteroaryl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 9- to 10-membered bicyclic heteroaryl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 3- to 10-membered monocyclic alkyl, an optionally substituted 7- to 10-membered bridged bicyclic alkyl, an optionally substituted 7- to 10-membered spirocyclic bicyclic alkyl, an optionally substituted 4- to 10-membered monocyclic heterocycloalkyl having 1 to 3 ring heteroatoms selected from oxygen, silicon, and nitrogen, or an optionally substituted 5- to 6-membered monocyclic heteroaryl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen. and nitrogen, optionally substituted 7-10 membered bridged bicyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 5-6 membered monocyclic cycloalkenyl, optionally substituted 8-10 membered bicyclic cycloalkenyl, optionally substituted 5-6 membered monocyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, and optionally substituted 8-10 membered bicyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen; and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl. or a pharmaceutically acceptable salt thereof.
[0176] 9. Ring B is [ka] (In the formula, w is 0 or 1; Y 4 and Y 5are each independently selected from optionally substituted —(CH)—, optionally substituted —(NH)—, and —O—; Y 6 is selected from optionally substituted —(CH)—, optionally substituted —(NH)—, tetraalkylsilane, and —O—; R 10 is selected from hydrogen, halogen, optionally substituted alkyl and carbonyl; and R 11 , R 12 and R 13 are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy. 9. The compound of any one of embodiments 1 to 8, or a pharmaceutically acceptable salt thereof, selected from:
[0177] 10. Ring B is [ka] (In the formula, R 11 and R 12 are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; R 14 is selected from hydrogen and optionally substituted alkyl; R is selected from hydrogen, optionally substituted alkyl and aryl; and R' is selected from hydrogen, optionally substituted alkyl and halogen. 10. The compound of any one of embodiments 1 to 9, or a pharmaceutically acceptable salt thereof, selected from:
[0178] 11. Ring B is [ka] (In the formula, R 11 , R 12 and R 13 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted amine, and optionally substituted alkoxy. 10. The compound of any one of embodiments 1 to 9, or a pharmaceutically acceptable salt thereof, selected from:
[0179] 12. Ring B is [ka] (In the formula, w is 0 or 1, Y 4 is selected from SO2, optionally substituted sulfonamide, optionally substituted amide, optionally substituted -(CH2)-, optionally substituted -(NH)-, and -O-; R 11 and R 12 are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; and Ring C is selected from a 5-membered aromatic ring, a 5-membered heteroaromatic ring containing one or two ring nitrogen atoms, a 6-membered aromatic ring, and a 6-membered heteroaromatic ring containing one or two ring nitrogen atoms. 9. The compound of any one of embodiments 1 to 8, or a pharmaceutically acceptable salt thereof, selected from:
[0180] 13. Ring B is [ka] (In the formula, Y 4 , Y 5 and Y 6 are each independently selected from optionally substituted —(CH)—, optionally substituted —(NH)—, and —O—; R11 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; and Ring C is selected from a 5-membered aromatic ring, a 5-membered heteroaromatic ring containing one or two ring nitrogen atoms, a 6-membered aromatic ring, and a 6-membered heteroaromatic ring containing one or two ring nitrogen atoms. 9. The compound of any one of embodiments 1 to 8, or a pharmaceutically acceptable salt thereof, selected from:
[0181] 14. Ring B is [ka] (In the formula, R 11 When is not attached to nitrogen, R 11 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 11 is otherwise selected from hydrogen and optionally substituted alkyl; R 12 When is not attached to nitrogen, R 12 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 12 is otherwise selected from hydrogen and optionally substituted alkyl; R 13 When is not attached to nitrogen, R 13 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 13 is otherwise selected from hydrogen and optionally substituted alkyl; and R 14 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy. 14. The compound of any one of embodiments 1 to 8 and 13, or a pharmaceutically acceptable salt thereof, selected from:
[0182] 15. Ring B is [ka] (In the formula, Y 4 and Y 5 are each independently selected from optionally substituted —(CH)—, optionally substituted —(NH)—, and —O—; and R 11 and R 12 are independently selected from hydrogen, cyano, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, aryl, heteroaryl, and optionally substituted alkoxy. 9. The compound of any one of embodiments 1 to 8, or a pharmaceutically acceptable salt thereof, selected from:
[0183] 16. Ring B is [ka] (In the formula, R 11 and R 12 are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy. 17. The compound of any one of embodiments 1 to 8 and 16, or a pharmaceutically acceptable salt thereof, selected from:
[0184] 17. Ring B is [ka] (In the formula, R 11 , R 12 and R 13 are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy. 9. The compound of any one of embodiments 1 to 8, or a pharmaceutically acceptable salt thereof, selected from:
[0185] 18. Ring B is [ka] (In the formula, Y 6 is selected from optionally substituted -(CH)- and optionally substituted -(NH)-; and R 11 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy. 16. The compound of any one of embodiments 1 to 8 and 15, or a pharmaceutically acceptable salt thereof, selected from:
[0186] 19. Ring B is [ka] (In the formula, Y 4 is selected from optionally substituted —(CH)—, optionally substituted —(NH)—, and —O—; Y 5 is selected from optionally substituted —(CH)— and N; and R 11 and R 12 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy. 9. The compound of any one of embodiments 1 to 8, or a pharmaceutically acceptable salt thereof, selected from:
[0187] 20. Ring B is [ka] (In the formula, R 11 and R 12is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy. 9. The compound of any one of embodiments 1 to 8, or a pharmaceutically acceptable salt thereof, selected from:
[0188] 21. Ring B is [ka] (In the formula, R 11 , R 12 and R 13 are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy. 13. The compound of any one of embodiments 1 to 8 and 12, or a pharmaceutically acceptable salt thereof, selected from:
[0189] 22.R 1 is -(CHR 5 ) k -(CR 6 R 7 ) n -(O) m - Ring B, wherein k is 0 or 1, n is 0 or 1, m is 0 or 1; R 5 is selected from hydrogen and methyl; R 6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen; and R 2 22. The compound or pharmaceutically acceptable salt of any one of embodiments 1-21, wherein is selected from hydrogen and methyl.
[0190] twenty three. [ka] (In the formula, Y 1 N and CX 1 Selected from X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; R 3 is selected from hydrogen, optionally substituted C1-C3 alkyl, halogen, cyano, and optionally substituted C1-C3 alkoxy; and R 4 is selected from hydrogen and alkyl; Y 4 is CH2, O and NR 11 Selected from; X 3 is selected from hydrogen and halogen; R' is selected from hydrogen and C1-C3 alkyl optionally substituted with at least one halogen; R 11 is selected from hydrogen and C1-C3 alkyl; R 12 is selected from hydrogen, halogen, and C1-C3 alkyl; and R 13 is selected from hydrogen, halogen, C2-C4 alkoxy and C1-C3 alkyl or a pharmaceutically acceptable salt thereof.
[0191] twenty four. [ka] (In the formula, X 1 is selected from hydrogen, hydroxyl, halogen and C1-C4 alkyl; X 3 is selected from hydrogen and halogen; and R 11 and R 12 are independently selected from hydrogen and C1-C3 alkyl 24. The compound of embodiment 23, or a pharmaceutically acceptable salt thereof, selected from:
[0192] 25. The compound or a pharmaceutically acceptable salt according to any one of embodiments 1-24, wherein optionally substituted alkyl is selected from haloalkyl.
[0193] 26. The compound or a pharmaceutically acceptable salt of embodiment 25, wherein haloalkyl is trifluoromethyl.
[0194] 27. 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(4-fluoro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-fluorophenyl)ethyl)piperidine-4-carboxamide; N-((1s,4s)-4-(difluoromethyl)cyclohexyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-(difluoromethyl)cyclohexyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; N-(4-methylcyclohexyl)-1-[5-(2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; 1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; N-((1s,4s)-4-ethylcyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-ethylcyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(3-chloropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; 1-[4-chloro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[4-chloro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; N-((1s,4s)-4-(difluoromethyl)cyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-(difluoromethyl)cyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-methylcyclohexyl)piperidine-4-carboxamide; (R)-1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-(3-chlorophenyl)ethyl]piperidine-4-carboxamide; (S)-1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-(3-chlorophenyl)ethyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(imidazo[1,2-a]pyridin-2-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(2-methyl-1,3-dioxan-5-yl)piperidine-4-carboxamide; N-((1H-indol-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,3,6-trifluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,3-dimethyl-1H-pyrazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-chloro-5-fluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-cyanocyclobutyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-methylpyridin-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(isochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,2S)-2-phenylcyclopropyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-hydroxycyclohexyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4,4-dimethyloxetan-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyloxazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrazolo[1,5-a]pyridin-7-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,5-dimethyl-1H-pyrazol-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(4-chlorophenoxy)propan-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3-difluorocyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methoxycyclobutyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-fluoropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(difluoromethyl)phenyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,3-difluorocyclobutyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,2-difluoro-2-phenylethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3,5-trimethylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-(difluoromethoxy)benzyl)piperidine-4-carboxamide; N-(benzo[d]oxazol-6-ylmethyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-fluorophenyl)ethyl)piperidine-4-carboxamide; N-(5-chloro-2-fluorobenzyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,3-difluorobenzyl)piperidine-4-carboxamide; N-(3-chloro-2-fluorobenzyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-fluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,4-dihydro-2H-pyran-2-yl)methyl)piperidine-4-carboxamide; N-(3-chlorobenzyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (1R,3s,5S)-N-(3-chlorobenzyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3r,5S)-N-(3-chlorobenzyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; N-(3-chlorobenzyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(trifluoromethyl)cyclopentyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1,4-dimethylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-(trifluoromethoxy)benzyl)piperidine-4-carboxamide; N-(bicyclo[3.2.1]octan-8-yl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-[(3-chlorophenyl)methyl]-1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-1,2,4-triazole-3-carbonyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-hydroxypiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-3-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-fluoropiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3-difluorocyclopentyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylpyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-3-fluoropiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(trifluoro-15-methyl)pyridin-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyridin-3-yl)methyl)piperidine-4-carboxamide; N-((1H-indazol-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-indol-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(isoquinolin-6-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-oxo-1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(chroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-1,2,3,4-tetrahydroquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indol-3-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylfuran-2-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,6,7,8-tetrahydroisoquinolin-5-yl)piperidine-4-carboxamide; N-((1H-indazol-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-7-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluorochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-phenylpiperidin-4-yl)piperidine-4-carboxamide; N-((2H-benzo[d][1,2,3]triazol-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; N-((3-fluoro-1H-indazol-5-yl)methyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-indazol-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1H-indol-5-yl)methyl)piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-methyl-1H-indazol-5-yl)methyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-isopropyl-1H-pyrazol-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-oxo-1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; N-(5-chloro-2,3-dihydrobenzofuran-3-yl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-c]pyridin-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,5-dimethyltetrahydrofuran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((8-fluoroimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1H-benzo[d]imidazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1,3-dioxan-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-methylimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indazol-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-chloroimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4,4-difluorotetrahydrofuran-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)oxazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(2-fluorophenyl)pyrrolidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-benzo[d]imidazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-5,6,7,8-tetrahydroquinazolin-5-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(difluoromethyl)isoxazol-3-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indazol-6-yl)methyl)piperidine-4-carboxamide; N-((2-oxabicyclo[3.1.1]heptan-1-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-2,2-dioxide-3,4-dihydro-1H-benzo[c][1,2]thiazin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-cyanochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-2-oxo-1,2,5,6,7,8-hexahydroquinolin-5-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,1-dioxide-2,3-dihydrobenzo[b]thiophen-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(difluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(difluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,3-dimethyl-2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-1H-benzo[d]imidazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-oxo-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; (S)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-azaspiro[2.5]octane-7-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-fluoro-3-methylcyclobutyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-methyltetrahydrofuran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; N-((1H-indol-2-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-methylpyridin-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-methoxychroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(4-fluorophenyl)pyrrolidin-3-yl)piperidine-4-carboxamide; N-((1H-pyrrolo[3,2-c]pyridin-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,2-dimethylpiperidine-4-carboxamide; (R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,2-dimethylpiperidine-4-carboxamide; (S)-5-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-5-azaspiro[3.5]nonane-8-carboxamide; (R)-5-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-5-azaspiro[3.5]nonane-8-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)—N-[(3-fluoro-1H-indazol-5-yl)methyl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,6-dimethylpyrazin-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1H-indol-4-yl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-2,3-dihydrobenzofuran-3-yl)piperidine-4-carboxamide; (2S,5R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,5S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,5R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,5S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; N-[(3-chlorophenyl)methyl]-1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; (1R,3S,5S)-N-[(3-chlorophenyl)methyl]-8-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; N-[(3-fluoro-1H-indazol-5-yl)methyl]-1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-ethylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(1H-indol-5-ylmethyl)piperidine-4-carboxamide; N-[(2,3-dimethyl-1H-indol-5-yl)methyl]-1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; (2R,4R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,6-dimethylpiperidine-4-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]nonan-7-yl)piperidine-4-carboxamide; (1R,3s,5S)—N-((3-fluoro-1-methyl-1H-indazol-5-yl)methyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; N-((3,3-dimethylindolin-5-yl)methyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (1R,3s,5S)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-methyl-1H-indazol-5-yl)ethyl)piperidine-4-carboxamide; 9-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-3-oxa-9-azabicyclo[3.3.1]nonane-7-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((3-fluoro-1H-indazol-5-yl)methyl)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)—N-[(2,3-dimethyl-1H-indol-5-yl)methyl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-fluoro-1H-indazol-5-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-fluoro-1H-indazol-5-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl)ethyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl)ethyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-(1,1-dimethylsilinan-4-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methoxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methoxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8r)-2-oxo-1-azaspiro[4.5]decan-8-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8s)-2-oxo-1-azaspiro[4.5]decan-8-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 4-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(R)-1-(2-fluorophenyl)pyrrolidin-3-yl]-4-azaspiro[2.5]octane-7-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-oxaspiro[3.5]nonan-7-yl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (2R,4S,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4S,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4R,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4S,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4S,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4R,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4R,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4R,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (1R,3S,5S)—N-[(3S,6S)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)—N-[(3S,6R)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)—N-[(3R,6S)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)—N-[(3S,6R)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-hydroxy-4-(perfluoroethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(difluoromethyl)-4-methoxycyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(difluoromethyl)-4-methoxycyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((1s,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(2-methoxyethoxy)-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(2-methoxyethoxy)-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-1,2,4-triazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1s,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(4-(5-hydroxy-2-methylpyridin-4-yl)-1H-imidazole-2-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.2]octan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.2]octan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(2,3-dimethylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(6-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(2-ethylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(2-(hydroxymethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(trifluoromethyl)-1-oxaspiro[3.5]nonan-7-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(3,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4S,7r)-1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4R,7s)-1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8r)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8s)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8r)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8s)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5S,8r)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5R,8s)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(2-(dimethylamino)ethoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-(2-hydroxyethoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-(2-hydroxyethoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.1]heptan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.1]heptan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-hydroxybicyclo[1.1.1]pentan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,4S)-4-((S)-2-methoxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,4S)-4-((R)-2-methoxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-4,5,6,7-tetrahydro-2H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-4,5,6,7-tetrahydro-2H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((R)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((R)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((S)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((S)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1r,4R)-N-((R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1s,4S)-N-((R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1r,4S)-N-((S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1s,4R)-N-((S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(oxetan-3-yl)-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(2-aminoethoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-(2,2-difluoropropyl)-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,4S)-4-((S)-2-aminopropoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,4S)-4-((S)-2-hydroxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(8-oxabicyclo[3.2.1]octan-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3R)-3-(3,3-difluoropyrrolidin-1-yl)-2,2-dimethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3S)-3-(3,3-difluoropyrrolidin-1-yl)-2,2-dimethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-3-(trifluoromethyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-3-(trifluoromethyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methylpyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(3-chloropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(3-chloropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-methylpyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)-2-oxabicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2S,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2S,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2R,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2R,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (R)-N-((1r,4R)-4-(1,1-difluoro-2-methoxyethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1s,4S)-4-(1,1-difluoro-2-methoxyethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1R,3S)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1S,3S)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-116-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1S,3R)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1R,3R)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(perfluoroethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-hydroxy-4-(perfluoroethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4S,7r)-3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4R,7s)-3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-(1,1-difluoroethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(1,1-difluoroethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6R,8aR)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6R,8aS)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6S,8aR)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6S,8aS)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(3-chloro-5-fluoropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(3-chloro-5-fluoropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,3R)-3-(3,3-difluoropyrrolidin-1-yl)-2,2,4,4-tetramethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,3S)-3-(3,3-difluoropyrrolidin-1-yl)-2,2,4,4-tetramethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-(2-fluoro-2-methylpropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-(2-fluoro-2-methylpropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-6-methyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-6-methyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-3-methyl-4,5,6,7-tetrahydro-1H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-3-methyl-4,5,6,7-tetrahydro-1H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-7-fluoro-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-7-fluoro-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-methylpyridazin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-chloro-2-methylpyrimidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloropyrazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-methoxypyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(pyridin-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(pyridin-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-cyanopyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(oxetan-3-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(3-cyanoazetidin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-5-(trifluoromethyl)oxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(oxetan-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(oxetan-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methylpyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(1,1-difluoro-3-methoxypropyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-(1,1-difluoro-3-methoxypropyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-amino-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-amino-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3,5-difluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2S,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2R,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2R,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2S,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (S)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2R,4S)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2S,4R)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2S,4S)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2R,4R)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-(4-methylpiperazin-1-yl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5S,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5R,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((1-fluorocyclopropyl)methyl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,2-dimethylpiperidine-4-carboxamide; (R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,2-dimethylpiperidine-4-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-(hydroxymethyl)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-(hydroxymethyl)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(1-(tert-butylsulfinyl)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4S,7r)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4R,7s)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(4-hydroxybicyclo[2.2.2]octan-1-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(4-hydroxybicyclo[2.2.2]octan-1-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4,6-dimethylpyridazin-3-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5-chloropyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,4R)-4-morpholinotetrahydrofuran-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,4S)-4-morpholinotetrahydrofuran-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrazolo[1,5-a]pyridin-7-ylmethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(oxetan-3-yl)piperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-morpholinocyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-morpholinocyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,5S,7r)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,5S,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(methylsulfonyl)piperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(oxetan-3-yl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(oxetan-3-yl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4S)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4S)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4R)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4R)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,6S)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,6R)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,6R)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,6S)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-fluoroethyl)-2,2-dimethylpiperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-fluoroethyl)-2,2-dimethylpiperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4R)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4S)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4R)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-methylpyrimidin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-methylpyrimidin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-(trifluoromethyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((S)-tetrahydrofuran-3-yl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((R)-tetrahydrofuran-3-yl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-((3-chloro-5-(3,5-dimethylpiperazin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)—N-(4-(1,1-difluoro-2-hydroxyethyl)-4-hydroxycyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(4-cyano-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)—N-((1s,4R)-4-(cyanomethyl)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(cyanomethyl)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-(2-fluoro-2-methylpropyl)-2-azabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)—N-(4-amino-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-(2-fluoro-2-methylpropyl)-2-azabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-(trifluoromethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-oxa-5-azaspiro[3.5]nonane-8-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-((R)-1-hydroxyethyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-((S)-1-hydroxyethyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(oxetan-3-yloxy)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-((5-(3,5-dimethylpiperazin-1-yl)pyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-cyanocyclopropyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(2-methoxy-5-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(1H-pyrazolo[3,4-b]pyridin-4-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N—((R)-1-(1H-pyrazolo[3,4-b]pyridin-4-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-6-methylpyrazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(6-methylpyridazin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(6-methylpyridazin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-methylpyrimidin-5-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-methylpyrimidin-5-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-((3-hydroxyoxetan-3-yl)methyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-((3-hydroxyoxetan-3-yl)methyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxypyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-cyanopyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-(3,5-dichloropyridin-2-yl)cyclopropyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(2,2-difluoro-3-hydroxypropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(2,2-difluoro-3-hydroxypropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,4S)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,4R)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-((R)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N—((R)-1-((S)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((R)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((S)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-3-chloropyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-3-chloropyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-((R)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N—((R)-1-((S)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((R)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((S)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,4,5-trimethyl-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-((1S,2S)-2-cyanocyclopropyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-((1R,2R)-2-cyanocyclopropyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluoropyrazolo[1,5-a]pyridin-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluoropyrazolo[1,5-a]pyridin-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,6R)-2,5-diazabicyclo[4.1.0]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,6S)-2,5-diazabicyclo[4.1.0]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-((1-hydroxycyclopropyl)methyl)pyrrolidin-3-yl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-((1-hydroxycyclopropyl)methyl)pyrrolidin-3-yl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyanopyrimidin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyanopyrimidin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3R,4S)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3S,4R)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,3R,4S)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,3S,4R)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((5-(trifluoromethyl)-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(5-(2-acetyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((S)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((S)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((R)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((R)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-cyclopropyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-cyclopropyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-((1S,2S)-2-(hydroxymethyl)cyclopropyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-((1R,2R)-2-(hydroxymethyl)cyclopropyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((2-((3S,5R)-3,5-dimethylpiperazin-1-yl)-5-(trifluoromethyl)oxazol-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-ethyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-ethyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)-2-((3S,5R)-3,4,5-trimethylpiperazin-1-yl)oxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-5-azaspiro[3.5]nonane-8-carboxamide; (R)-5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-5-azaspiro[3.5]nonane-8-carboxamide; (S)—N-(5-cyanopyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(1-(6-cyanopyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyanopyridin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyanopyridin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-(5-methylpyrazin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-(5-methylpyrazin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-isopropoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxy-3-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxy-3-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(6-acetylpyrazolo[1,5-a]pyridin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-((S)-1-hydroxyethyl)pyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-((R)-1-hydroxyethyl)pyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-N-(7',8'-dihydro-6'H-spiro[oxetan-3,5'-quinoline]-8'-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(5-ethyl-2-oxa-5-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5,5-dimethyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1-(aminomethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3R,4S)-3-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3S,4R)-3-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((4-(trifluoromethyl)-1H-imidazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2R,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2S,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2R,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2S,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2R,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2S,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2R,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2S,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)isoxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-cyclopropylpyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-cyclopropylpyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-4-(trifluoromethyl)-1H-pyrazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-5-(trifluoromethyl)-1H-1,2,3-triazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(((S)-3,3-difluoropiperidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(((R)-3,3-difluoropiperidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((5-fluoropyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-5-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-5-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-methyl-4-(trifluoromethyl)thiazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(hydroxymethyl)-3-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(hydroxymethyl)-3-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-(trifluoromethyl)-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(hydroxymethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(4-methylpiperazin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3S)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3S)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3R)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3R)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)pyridin-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxy-3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(6-cyanopyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(6-cyanopyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(2-chloro-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(2-chloro-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxy-3-(trifluoromethyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide and pharmaceutically acceptable salts thereof.
[0195] 28. A pharmaceutical composition comprising at least one entity selected from the compound according to any one of embodiments 1 to 27 and pharmaceutically acceptable salts thereof.
[0196] 29. The pharmaceutical composition according to embodiment 28, further comprising at least one pharmaceutically acceptable carrier.
[0197] 30. A method for treating and / or preventing cancer, comprising administering to a subject in need thereof an effective amount of at least one entity selected from the compounds of formula (I) as defined in any one of embodiments 1 to 27 and their pharmaceutically acceptable salts, and the pharmaceutical compositions as defined in embodiment 28 or 29.
[0198] 31. The method of embodiment 30, wherein the cancer is selected from bladder cancer, breast cancer, prostate cancer and / or cancer with an altered RXRα and / or PPARγ pathway.
[0199] 32. The method of embodiment 30 or 31, wherein the cancer is bladder cancer.
[0200] 33. The method according to any one of embodiments 30 to 32, wherein the bladder cancer is advanced bladder cancer, luminal bladder cancer and / or basal cell bladder cancer.
[0201] 34. The method of any one of embodiments 30 to 33, wherein the cancer is a chemotherapy-resistant and / or immunotherapy-resistant cancer.
[0202] 35. Use of at least one entity selected from compounds of formula (I) as defined in any one of embodiments 1 to 27 and pharmaceutically acceptable salts thereof, and pharmaceutical compositions as defined in embodiment 28 or 29, in the treatment and / or prevention of cancer.
[0203] 36. The use according to embodiment 35, wherein the cancer is selected from bladder cancer, breast cancer, prostate cancer and / or cancer with an altered RXRα and / or PPARγ pathway.
[0204] 37. The use according to embodiments 35 and 36, wherein the cancer is bladder cancer.
[0205] 38. The use according to any one of embodiments 35 to 37, wherein the bladder cancer is advanced bladder cancer, luminal bladder cancer and / or basal cell bladder cancer.
[0206] 39. The use according to any one of embodiments 35 to 38, wherein the cancer is a chemotherapy-resistant and / or immunotherapy-resistant cancer.
[0207] 40. TR-FRET inverse agonist AC less than 1000 nM, less than 500 nM, or less than 250 nM 50 28. The compound or pharmaceutically acceptable salt of any one of embodiments 1 to 27, having a value:
[0208] 41.R 1 28. The compound or pharmaceutically acceptable salt of any one of embodiments 1 to 27, wherein m is 0.
[0209] 42.R 8 or R 9or a pharmaceutically acceptable salt thereof.
[0210] 43. The compound has the formula (IIB) and the formula (IIIB): [ka] (In the formula, q is 0 or 1; and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl. 43. The compound or pharmaceutically acceptable salt of any one of embodiments 1 to 27 and 40 to 42, wherein the compound is selected from the group consisting of:
[0211] In order that the disclosure described herein may be more fully understood, the following examples are set forth. Other embodiments of the present disclosure may be synthesized and tested using the reaction schemes and assays described below. It should be understood that these examples are for illustrative purposes only and should not be construed as limiting the disclosure in any manner. [Example]
[0212] In the following illustrative examples, unless otherwise stated: (i) Temperatures are given in degrees Celsius (°C); (ii) Organic solutions were dried over anhydrous sodium sulfate or magnesium sulfate unless otherwise stated; evaporation of organic solvents was carried out using a rotary evaporator under reduced pressure (5-1000 mbar) at a bath temperature of 60°C or less; (iii) column chromatography refers to silica gel flash chromatography or pre-packed silica gel cartridges (12, 24, 40 g, etc.); thin-layer chromatography (TLC) was performed on silica gel plates; (iv) Normal-phase and reverse-phase flash column chromatography was performed using either a Teledyne ISCO CombiFlash® system or Biotage® flash columns, which were used according to the manufacturer's instructions and obtained from 4700 Superior Street, Lincoln NE 68504, USA or Biotage AB Box 8 751 03 Uppsala Sweden, respectively; (v) Prep-TLC refers to the preparative TLC plate used for purification; (vi) In general, the course of reactions was followed by TLC or liquid chromatography / mass spectroscopy (LC / MS). Reaction times are provided for illustration only; (vii) the final product has satisfactory proton nuclear magnetic resonance (NMR) spectrum and / or mass spectrum data; (viii) If further material was required, the preparation was repeated; (ix) When NMR data are provided, it is in the form of delta values of major diagnostic protons given in parts per million (ppm) relative to tetramethylsilane (TMS, δ 0 ppm) as an internal standard; (x) Chemical symbols have their ordinary meanings; (xi) if the nomenclature assigned to a given compound does not correspond to the compound structure depicted herein, the structure shall control; (xii) Prep-HPLC means preparative high performance liquid chromatography, which refers to purification using the reversed-phase HPLC columns listed below, used according to the manufacturer's instructions, unless otherwise specified; Sunfire Prep C18 OBD column, 19 × 150 mm, 5 μm, 10 nm, in MeCN / H2O containing 0.1% formic acid or 0.05% TFA as the mobile phase, obtained from Waters, Building 13, Jinlingzhidu, 1000 Jinhai Road, Pudong New Area, Shanghai. XBridge Prep OBD C18 column, 19 × 250 mm or 30 × 150 mm or 30 × 50 mm, 5 μm, in MeCN / H2O containing 10 mM NH4HCO3 as the mobile phase, obtained from Waters, Building 13, Jinlingzhidu, 1000 Jinhai Road, Pudong New Area, Shanghai. YMC-Actus Triart C18 column, 20 × 250 mm or 30 × 250 mm, 5 μm, 12 nm, in MeCN / H2O containing 0.1% or 1 mM formic acid or 10 mM NH4HCO3 as the mobile phase, obtained from YMC CO., LTD., Far East International Plaza A2404, No. 319 Xianxia Road, Shanghai 200051, PRChina. Gemini-NX C18 AXAI packed column, 21.2 × 150 mm, 5 μm, in MeCN / H2O containing 0.1% formic acid as the mobile phase, obtained from Phenomenex, No. 179, Southern Street West TEDA, Tianjin, 300462. XBridge Shield RP18 OBD column, 30 × 150 mm, 5 μm, in MeCN / H2O containing 10 mM NH4HCO3 as the mobile phase, available from Waters, Building 13, Jinlingzhidu, 1000 Jinhai Road, Pudong New Area, Shanghai. Atlantis HILIC OBD column, 19 × 150 mm, 5 μm, 10 nm, in MeCN / H2O containing 0.1% formic acid as the mobile phase, available from Waters, Building 13, Jinlingzhidu, 1000 Jinhai Road, Pudong New Area, Shanghai. XBridge BEH130 Prep C18 OBD column, 130 Å, 19 × 150 mm, 5 μm, 13 nm, in MeCN / H2O containing 20 mM NH4HCO3 or 10 mM NH4HCO3 and 0.1% NH3H2O as the mobile phase, obtained from Waters, Building 13, Jinlingzhidu, 1000 Jinhai Road, Pudong New Area, Shanghai. XSelect CSH Prep C18 OBD columns, 19 × 150 mm or 30 × 50 mm, 30 × 150 mm, 5 μm, in MeCN / H2O containing 0.1% or 0.05% formic acid or 10 mM NH4HCO3 as the mobile phase, available from Waters, Building 13, Jinlingzhidu, 1000 Jinhai Road, Pudong New Area, Shanghai. Xselect CSH F-Phenyl OBD column, 19 × 250 mm, 5 μm, in MeCN / H2O containing 10 mM NH4HCO3 as the mobile phase, obtained from Waters, Building 13, Jinlingzhidu, 1000 Jinhai Road, Pudong New Area, Shanghai. Ascentis Express C18 OBD column, 50 × 2.1 mm, in MeCN / H2O containing 0.1% NH4HCO3 as the mobile phase, obtained from Sigma-Aldrich, 15F-18F, Building C, Qiantan World Trade Center (Phase II), No. 3, Lane 227, Dongyu Road, Pudong New Area, Shanghai, China. Xbridge C18 column, 100 × 19 mm, 5 μm, mobile phase: MeCN / H2O containing 0.1% NH4OH, obtained from Waters, 34 Maple Street, Milford, MA 01757, USA CSH C18 column, 100 × 19 mm, 5 μm, in MeCN / H2O containing 0.1% formic acid as the mobile phase, obtained from Waters, 34 Maple Street, Milford, MA 01757, USA (xiii) Chiral-Prep-HPLC means chiral preparative high performance liquid chromatography, which refers to purification using the chiral HPLC columns listed below, used according to the manufacturer's instructions, unless otherwise specified; Viridis BEH Prep OBD column, 1.9 × 15 cm, 5 μm, in hexane / IPA as the mobile phase, available from Waters, Building 13, jinlingzhidu, 1000 Jinhai Road, Pudong New Area, Shanghai. CHIRAL ART Cellulose-SB column, 2 × 25 cm or 3 × 25 cm, 5 μm, with mobile phases of MTBE / MeOH containing 2 mM NH3 in MeOH, hexane / EtOH containing 10 mM NH3 in MeOH, hexane / IPA containing 10 mM NH3 in MeOH, MTBE / IPA containing 0.5% 2M NH3 in MeOH, MTBE / MeOH containing 0.5% 2M NH3 in MeOH, or hexane / EtOH containing 8 mM NH3 in MeOH, available from YMC CO., LTD., Far East International Plaza A2404, No. 319 Xianxia Road, Shanghai 200051, PRChina. Gemini-NX C18 AXAI packed column, 21.2 × 150 mm, 5 μm, in MeCN / H2O containing 0.1% formic acid as the mobile phase, obtained from Phenomenex, No. 149, Southern Avenue, western district, TEDA, Tianjin, China. (xiv)...
Claims
1. Formula (I) [Formula 1] (In the formula, Ar 1 teeth, [Case 2] is selected from the group consisting of Y 1 is N and C-X 1 is selected from 1 is hydrogen, hydroxyl, halogen and C 1 ~C 4 alkyl; R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, halogen, cyano, and optionally substituted alkoxy; and R 4 is selected from hydrogen and optionally substituted alkyl; Y 2 is C-X 2 and N; and Y 3 is NH or Y 2 is NH, and Y 3 is C-X 2 or X 2 is selected from hydrogen and halogen; Ring A is selected from saturated 6-9 membered cyclic rings optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl; R 1 is -(CHR 5 ) k - (CR 6 R 7 ) n - (O) m - Ring B, wherein k is 0 or 1; n is 0 or 1; m is 0 or 1; R 5is selected from hydrogen and optionally substituted alkyl; R 6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen; and Ring B is optionally substituted aryl; optionally substituted heteroaryl; optionally substituted cycloalkyl; optionally substituted heterocycloalkyl; optionally substituted cycloalkenyl, and Optionally substituted heterocycloalkenyl is selected from; and R 2 is selected from hydrogen and optionally substituted alkyl. or a pharma- ceutically acceptable salt thereof.
2. 2. The compound or pharma- ceutically acceptable salt of claim 1, wherein Ring A is selected from piperidinyl and a saturated 7-9 membered bicyclic ring, and Ring A is optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl.
3. 3. The compound or pharma- ceutically acceptable salt of claim 1 or 2, wherein Ring A is selected from piperidinyl, azaspirooctane, azaspirononane, azabicyclooctane, and oxazabicyclononane, and Ring A is optionally substituted with at least one substituent selected from halogen, hydroxyl, and optionally substituted alkyl.
4. Ring B is optionally substituted 5-10 membered aryl; optionally substituted 5-10 membered heteroaryl; optionally substituted 3- to 10-membered cycloalkyl; optionally substituted 4-10 membered heterocycloalkyl; optionally substituted 6- to 10-membered cycloalkenyl, and optionally substituted 6-10 membered heterocycloalkenyl The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 3, selected from:
5. Ring B is an optionally substituted 5-6 membered monocyclic aryl, an optionally substituted 10 membered bicyclic aryl, an optionally substituted 5-6 membered monocyclic heteroaryl, an optionally substituted 9-10 membered bicyclic heteroaryl, an optionally substituted 3-10 membered monocyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered spirocyclic bicyclic alkyl, an optionally substituted 4-10 membered monocyclic heterocycloalkyl, an optionally substituted 5-6 membered monocyclic heteroaryl, an optionally substituted 9-10 membered bicyclic heteroaryl, an optionally substituted 3-10 membered monocyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered spirocyclic bicyclic alkyl, an optionally substituted 4-10 membered monocyclic heterocycloalkyl, an optionally substituted 5-10 membered monocyclic heteroaryl ...
5. The compound or pharma- ceutically acceptable salt of any one of claims 1 to 4, selected from substituted 7-10 membered bridged bicyclic heterocycloalkyl, optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyl, optionally substituted 5-6 membered monocyclic cycloalkenyl, optionally substituted 8-10 membered bicyclic cycloalkenyl, optionally substituted 5-6 membered monocyclic heterocycloalkenyl, and optionally substituted 8-10 membered bicyclic heterocycloalkenyl.
6. Ring B is an optionally substituted 5-6 membered monocyclic aryl, an optionally substituted 10 membered bicyclic aryl, an optionally substituted 5-6 membered monocyclic heteroaryl having 1-3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 9-10 membered bicyclic heteroaryl having 1-3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 3-10 membered monocyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered spirocyclic bicyclic alkyl, an optionally substituted 4-10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon and nitrogen ...7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-1 6. The compound of any one of claims 1 to 5, or a pharma- ceutically acceptable salt thereof, selected from optionally substituted 7-10 membered bridged bicyclic heterocycloalkyl having ring heteroatoms, optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 5-6 membered monocyclic cycloalkenyl, optionally substituted 8-10 membered bicyclic cycloalkenyl, optionally substituted 5-6 membered monocyclic heterocycloalkenyl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen, and optionally substituted 8-10 membered bicyclic heterocycloalkenyl having 1 to 3 ring heteroatoms selected from oxygen and nitrogen.
7. Ring A is [C3] (In the formula, q is 0 or 1, and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl.
7. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 6, selected from:
8. Formulas (II) to (V): [C4] (In the formula, Y 1 is N and C-X 1 is selected from 1 is hydrogen, hydroxyl, halogen and C 1 ~C 4 alkyl; R 3 is selected from hydrogen, optionally substituted alkyl, optionally substituted amine, halogen, cyano, and optionally substituted alkoxy; R 4 is selected from hydrogen and alkyl; and Y 2 is C-X 2 and N; and Y 3 is NH, or Y 2 is NH, and Y 3 is C-X 2 or X 2 is selected from hydrogen and halogen; q is 0 or 1; R 1 is -(CHR 5 ) k - (CR 6 R 7 ) n - (O) m - Ring B, wherein k is 0 or 1; n is 0 or 1; m is 0 or 1; R 5 is selected from hydrogen and optionally substituted alkyl; R 6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen; and Ring B is an optionally substituted 5-6 membered monocyclic aryl, an optionally substituted 10 membered bicyclic aryl, an optionally substituted 5-6 membered monocyclic heteroaryl having 1-3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 9-10 membered bicyclic heteroaryl having 1-3 ring heteroatoms selected from oxygen and nitrogen, an optionally substituted 3-10 membered monocyclic alkyl, an optionally substituted 7-10 membered bridged bicyclic alkyl, an optionally substituted 7-10 membered spirocyclic bicyclic alkyl, an optionally substituted 4-10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon and nitrogen ...10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon and nitrogen, an optionally substituted 5-10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon and nitrogen, an optionally substituted 5-10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon and nitrogen, an optionally substituted 5-10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon and nitrogen, an optionally substituted 5-10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon and nitrogen, an optionally substituted 5-10 membered monocyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen, silicon optionally substituted 7-10 membered bridged bicyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 7-10 membered spirocyclic bicyclic heterocycloalkyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, optionally substituted 5-6 membered monocyclic cycloalkenyl, optionally substituted 8-10 membered bicyclic cycloalkenyl, optionally substituted 5-6 membered monocyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen, and optionally substituted 8-10 membered bicyclic heterocycloalkenyl having 1-3 ring heteroatoms selected from oxygen and nitrogen; R 2 is selected from hydrogen and optionally substituted alkyl; and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl.
2. The compound of claim 1, selected from the group consisting of:
9. Ring B is [C5] (In the formula, w is 0 or 1; Y 4 and Y 5are each independently an optionally substituted —(CH 2 )-, optionally substituted -(NH)-, and -O-; Y 6 is an optionally substituted -(CH 2 )-, optionally substituted -(NH)-, tetraalkylsilane, and -O-; R 10 is selected from hydrogen, halogen, optionally substituted alkyl and carbonyl; and R 11 , R 12 and R 13 are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
9. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8, selected from:
10. Ring B is [C6] (In the formula, R 11 and R 12 are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; R 14 is selected from hydrogen and optionally substituted alkyl; R is selected from hydrogen, optionally substituted alkyl and aryl; and R' is selected from hydrogen, optionally substituted alkyl and halogen.
10. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 9, selected from:
11. Ring B is [C7] (In the formula, R 11 , R 12 and R 13 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkyl, optionally substituted amine, and optionally substituted alkoxy.
10. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 9, selected from:
12. Ring B is [C8] (In the formula, w is 0 or 1, Y 4 , SO 2 , optionally substituted sulfonamide, optionally substituted amide, optionally substituted —(CH 2 )-, optionally substituted -(NH)-, and -O-; R 11 and R 12 are each independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; and Ring C is selected from a 5-membered aromatic ring, a 5-membered heteroaromatic ring containing one or two ring nitrogen atoms, a 6-membered aromatic ring, and a 6-membered heteroaromatic ring containing one or two ring nitrogen atoms.
9. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8, selected from:
13. Ring B is [C9] (In the formula, Y 4 , Y 5 and Y 6 are each independently selected from optionally substituted -(CH)-, optionally substituted -(NH)-, and -O-; R 11 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy; and Ring C is selected from a 5-membered aromatic ring, a 5-membered heteroaromatic ring containing one or two ring nitrogen atoms, a 6-membered aromatic ring, and a 6-membered heteroaromatic ring containing one or two ring nitrogen atoms.
9. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8, selected from:
14. Ring B is [C10] (In the formula, R 11 When is not attached to nitrogen, R 11 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 11 is otherwise selected from hydrogen and optionally substituted alkyl; R 12 When is not attached to nitrogen, R 12 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 12 is otherwise selected from hydrogen and optionally substituted alkyl; R 13 When is not attached to nitrogen, R 13 is selected from hydrogen, halogen, optionally substituted alkyl and hydroxyl, and R 13 is otherwise selected from hydrogen and optionally substituted alkyl; and R 14 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
14. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8 or 13, selected from:
15. Ring B is [C11] (In the formula, Y 4 and Y 5 are each independently an optionally substituted —(CH 2)-, optionally substituted -(NH)-, and -O-; and R 11 and R 12 are independently selected from hydrogen, cyano, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, aryl, heteroaryl, and optionally substituted alkoxy.
9. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8, selected from:
16. Ring B is [C12] (In the formula, R 11 and R 12 are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
17. The compound or pharma- ceutically acceptable salt of any one of claims 1 to 8 or 16, selected from:
17. Ring B is [C13] (In the formula, R 11 , R 12 and R 13 are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
9. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8, selected from:
18. Ring B is [C14] (In the formula, Y 6 is selected from optionally substituted -(CH)- and optionally substituted -(NH)-; and R 11is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
16. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8 or 15, selected from:
19. Ring B is [C15] (In the formula, Y 4 is an optionally substituted -(CH 2 )-, optionally substituted -(NH)-, and -O-; Y 5 is selected from optionally substituted —(CH)— and N; and R 11 and R 12 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
9. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8, selected from:
20. Ring B is [C16] (In the formula, R 11 and R 12 is selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
9. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8, selected from:
21. Ring B is [C17] (In the formula, R 11 , R 12 and R 13are independently selected from hydrogen, halogen, optionally substituted alkyl, hydroxyl, optionally substituted amine, and optionally substituted alkoxy.
13. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 8 or 12, selected from:
22. R 1 is -(CHR 5 ) k - (CR 6 R 7 ) n - (O) m - Ring B, wherein k is 0 or 1; n is 0 or 1; m is 0 or 1; R 5 is selected from hydrogen and methyl; R 6 is selected from hydrogen and halogen; R 7 is selected from hydrogen and halogen; and R 2 22. The compound or pharma- ceutically acceptable salt of any one of claims 1 to 21, wherein is selected from hydrogen and methyl.
23.
18. (In the formula, Y 1 is N and C-X 1 is selected from 1 is hydrogen, hydroxyl, halogen and C 1 ~C 4 alkyl; R 3 is hydrogen, optionally substituted C 1 ~C 3 Alkyl, halogen, cyano and optionally substituted C 1 ~C 3 alkoxy; and R 4 is selected from hydrogen and alkyl; Y 4 is CH 2 , O and N-R 11 Selected from: X 3 is selected from hydrogen and halogen; R' is a C optionally substituted with hydrogen and at least one halogen. 1 ~C 3 alkyl; R 11 is hydrogen and C 1 ~C 3 alkyl; R 12 is hydrogen, halogen and C 1 ~C 3 alkyl; and R 13 is hydrogen, halogen, C 2 ~C 4 Alkoxy and C 1 ~C 3 alkyl) or a pharma- ceutically acceptable salt thereof.
24.
19. (In the formula, X 1 is hydrogen, hydroxyl, halogen and C 1 ~C 4 alkyl; X 3 is selected from hydrogen and halogen; and R 11 and R 12 is hydrogen and C 1 ~C 3 alkyl) 24. The compound of claim 23, or a pharma- ceutically acceptable salt thereof, selected from:
25. 25. The compound or pharma- ceutically acceptable salt of any one of claims 1 to 24, wherein said optionally substituted alkyl is selected from haloalkyl.
26. 26. The compound or pharma- ceutically acceptable salt of claim 25, wherein said haloalkyl is trifluoromethyl.
27. 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(4-fluoro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-fluorophenyl)ethyl)piperidine-4-carboxamide; N-((1s,4s)-4-(difluoromethyl)cyclohexyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-(difluoromethyl)cyclohexyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; N-(4-methylcyclohexyl)-1-[5-(2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; 1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; N-((1s,4s)-4-ethylcyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-ethylcyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(3-chloropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-methylcyclohexyl)piperidine-4-carboxamide; 1-[4-chloro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[4-chloro-5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methylcyclohexyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; N-((1s,4s)-4-(difluoromethyl)cyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1r,4r)-4-(difluoromethyl)cyclohexyl)-1-(5-(2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-methylcyclohexyl)piperidine-4-carboxamide; (R)-1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-(3-chlorophenyl)ethyl]piperidine-4-carboxamide; (S)-1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-(3-chlorophenyl)ethyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(imidazo[1,2-a]pyridin-2-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(2-methyl-1,3-dioxan-5-yl)piperidine-4-carboxamide; N-((1H-indol-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,3,6-trifluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,3-dimethyl-1H-pyrazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-chloro-5-fluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-cyanocyclobutyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-methylpyridin-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(isochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,2S)-2-phenylcyclopropyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-hydroxycyclohexyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4,4-dimethyloxetan-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyloxazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrazolo[1,5-a]pyridin-7-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,5-dimethyl-1H-pyrazol-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(4-chlorophenoxy)propan-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3-difluorocyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methoxycyclobutyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-fluoropyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(difluoromethyl)phenyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,3-difluorocyclobutyl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,2-difluoro-2-phenylethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3,5-trimethylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-(difluoromethoxy)benzyl)piperidine-4-carboxamide; N-(benzo[d]oxazol-6-ylmethyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-fluorophenyl)ethyl)piperidine-4-carboxamide; N-(5-chloro-2-fluorobenzyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2,3-difluorobenzyl)piperidine-4-carboxamide; N-(3-chloro-2-fluorobenzyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-fluorobenzyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,4-dihydro-2H-pyran-2-yl)methyl)piperidine-4-carboxamide; N-(3-chlorobenzyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (1R,3s,5S)-N-(3-chlorobenzyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3r,5S)-N-(3-chlorobenzyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; N-(3-chlorobenzyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(trifluoromethyl)cyclopentyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1,4-dimethylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-(trifluoromethoxy)benzyl)piperidine-4-carboxamide; N-(bicyclo[3.2.1]octan-8-yl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-[(3-chlorophenyl)methyl]-1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-1,2,4-triazole-3-carbonyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-hydroxypiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-3-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-fluoropiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,3-difluorocyclopentyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylpyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-3-fluoropiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(trifluoro-15-methyl)pyridin-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-chloropyridin-3-yl)methyl)piperidine-4-carboxamide; N-((1H-indazol-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-indol-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(isoquinolin-6-ylmethyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-oxo-1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(chroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-1,2,3,4-tetrahydroquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indol-3-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylfuran-2-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,6,7,8-tetrahydroisoquinolin-5-yl)piperidine-4-carboxamide; N-((1H-indazol-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; N-((1H-indol-7-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluorochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-phenylpiperidin-4-yl)piperidine-4-carboxamide; N-((2H-benzo[d][1,2,3]triazol-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; N-((3-fluoro-1H-indazol-5-yl)methyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-indazol-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1H-indol-5-yl)methyl)piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-methyl-1H-indazol-5-yl)methyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-isopropyl-1H-pyrazol-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-oxo-1-phenylpyrrolidin-3-yl)piperidine-4-carboxamide; N-(5-chloro-2,3-dihydrobenzofuran-3-yl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methylimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-c]pyridin-5-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,5-dimethyltetrahydrofuran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((8-fluoroimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1H-benzo[d]imidazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-1,3-dioxan-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-methylimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indazol-3-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-chloroimidazo[1,2-a]pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4,4-difluorotetrahydrofuran-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)oxazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(2-fluorophenyl)pyrrolidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-benzo[d]imidazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-5,6,7,8-tetrahydroquinazolin-5-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(difluoromethyl)isoxazol-3-yl)methyl)piperidine-4-carboxamide; N-((1H-pyrrolo[2,3-b]pyridin-6-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-indazol-6-yl)methyl)piperidine-4-carboxamide; N-((2-oxabicyclo[3.1.1]heptan-1-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-2,2-dioxide-3,4-dihydro-1H-benzo[c][1,2]thiazin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-cyanochroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-methyl-2-oxo-1,2,5,6,7,8-hexahydroquinolin-5-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,1-dioxide-2,3-dihydrobenzo[b]thiophen-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(difluoromethyl)pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6-(difluoromethyl)pyridin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3,3-dimethyl-2-oxoindolin-5-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-1H-benzo[d]imidazol-4-yl)methyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-oxo-1,2,3,4-tetrahydroisoquinolin-4-yl)piperidine-4-carboxamide; (S)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-4-azaspiro[2.5]octane-7-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-fluoro-3-methylcyclobutyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-methyltetrahydrofuran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)piperidine-4-carboxamide; N-((1H-indol-2-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-methylpyridin-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-methoxychroman-4-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(4-fluorophenyl)pyrrolidin-3-yl)piperidine-4-carboxamide; N-((1H-pyrrolo[3,2-c]pyridin-4-yl)methyl)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,2-dimethylpiperidine-4-carboxamide; (R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,2-dimethylpiperidine-4-carboxamide; (S)-5-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-5-azaspiro[3.5]nonane-8-carboxamide; (R)-5-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-5-azaspiro[3.5]nonane-8-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-N-[(3-fluoro-1H-indazol-5-yl)methyl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5,6-dimethylpyrazin-2-yl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1H-indol-4-yl)piperidine-4-carboxamide; 1-[5-(5-chloro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4s)-4-hydroxy-4-methylcyclohexyl)piperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-methyl-2,3-dihydrobenzofuran-3-yl)piperidine-4-carboxamide; (2S,5R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,5S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,5R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,5S)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,5-dimethylpiperidine-4-carboxamide; N-[(3-chlorophenyl)methyl]-1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; (1R,3S,5S)-N-[(3-chlorophenyl)methyl]-8-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; N-[(3-fluoro-1H-indazol-5-yl)methyl]-1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; 1-[5-(5-chloro-2-ethylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(3-chlorophenyl)methyl]piperidine-4-carboxamide; 1-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-(1H-indol-5-ylmethyl)piperidine-4-carboxamide; N-[(2,3-dimethyl-1H-indol-5-yl)methyl]-1-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]piperidine-4-carboxamide; (2R,4R)-1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2-methylpiperidine-4-carboxamide; 1-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-chlorobenzyl)-2,6-dimethylpiperidine-4-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]non-7-yl)piperidine-4-carboxamide; (1R,3s,5S)—N-((3-fluoro-1-methyl-1H-indazol-5-yl)methyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; N-((3,3-dimethylindolin-5-yl)methyl)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)piperidine-4-carboxamide; (1R,3s,5S)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(3-methyl-1H-indazol-5-yl)ethyl)piperidine-4-carboxamide; 9-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-3-oxa-9-azabicyclo[3.3.1]nonane-7-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-((3-fluoro-1H-indazol-5-yl)methyl)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-N-[(2,3-dimethyl-1H-indol-5-yl)methyl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-chloro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-fluoro-1H-indazol-5-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-fluoro-1H-indazol-5-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-6-(trifluoromethyl)tetrahydro-2H-pyran-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl)ethyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl)ethyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-(1,1-dimethylsilylan-4-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-methoxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-methoxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8r)-2-oxo-1-azaspiro[4.5]decan-8-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8s)-2-oxo-1-azaspiro[4.5]decan-8-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; 4-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(R)-1-(2-fluorophenyl)pyrrolidin-3-yl]-4-azaspiro[2.5]octane-7-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[1-oxaspiro[3.5]nonan-7-yl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (2R,4S,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4S,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4R,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4S,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4S,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4R,5S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2R,4R,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (2S,4R,5R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,5-dimethylpiperidine-4-carboxamide; (1R,3S,5S)-N-[(3S,6S)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-N-[(3S,6R)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-N-[(3R,6S)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-N-[(3S,6R)-1-ethyl-6-(trifluoromethyl)piperidin-3-yl]-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(4-hydroxy-4-(perfluoroethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(difluoromethyl)-4-methoxycyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3R,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(difluoromethyl)-4-methoxycyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-((1s,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1r,4r)-4-(2-methoxyethoxy)-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl]-N-[(1s,4s)-4-(2-methoxyethoxy)-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3S,5S)-8-[5-(5-fluoro-2-methoxypyridin-4-yl)-1H-1,2,4-triazole-3-carbonyl]-N-[(1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl]-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((1s,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1s,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(4-(5-hydroxy-2-methylpyridin-4-yl)-1H-imidazole-2-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.2]octan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.2]octan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(2,3-dimethylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(6-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(2-ethylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-8-(5-(2-(hydroxymethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(trifluoromethyl)-1-oxaspiro[3.5]nonan-7-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-(3,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-N-(4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-methyl-6-(trifluoromethyl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-ethoxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-methoxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4S,7r)-1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4R,7s)-1-oxaspiro[3.5]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6S)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6S)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,6R)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,6R)-1-(2-fluoro-2-methylpropyl)-6-(trifluoromethyl)piperidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8r)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8s)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5S,8r)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5R,8s)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5S,8r)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5R,8s)-1-ethyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(2-(dimethylamino)ethoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-(2-hydroxyethoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-(2-hydroxyethoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.1]heptan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.2.1]heptan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-hydroxybicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-hydroxybicyclo[1.1.1]pentan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methoxypyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(6-methylpyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,4S)-4-((S)-2-methoxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,4S)-4-((R)-2-methoxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-4,5,6,7-tetrahydro-2H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-4,5,6,7-tetrahydro-2H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((R)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((R)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((S)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((S)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((R)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(((S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1r,4R)-N-((R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1s,4S)—N—((R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1r,4S)-N-((S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (1s,4R)-N-((S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octan-7-yl)-4-hydroxy-4-(trifluoromethyl)cyclohexane-1-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(oxetan-3-yl)-1-azaspiro[4.5]decan-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(2-aminoethoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-(2,2-difluoropropyl)-1-azaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,4S)-4-((S)-2-aminopropoxy)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,4S)-4-((S)-2-hydroxypropoxy)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(8-oxabicyclo[3.2.1]octan-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3R)-3-(3,3-difluoropyrrolidin-1-yl)-2,2-dimethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3S)-3-(3,3-difluoropyrrolidin-1-yl)-2,2-dimethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-3-(trifluoromethyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-3-(trifluoromethyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methylpyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(3-chloropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(3-chloropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-methylpyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)-2-oxabicyclo[2.1.1]hexan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2S,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2S,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2R,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (2R,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-(trifluoromethyl)piperidine-4-carboxamide; (R)—N-((1r,4R)-4-(1,1-difluoro-2-methoxyethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((1s,4S)-4-(1,1-difluoro-2-methoxyethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1R,3S)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1S,3S)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1S,3R)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((1R,3R)-1-imino-2,2-dimethyl-1-oxidetetrahydro-1H-11-6-thiophen-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(perfluoroethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-hydroxy-4-(perfluoroethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4S,7r)-3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4R,7s)-3,3-difluoro-1-oxaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-(1,1-difluoroethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(1,1-difluoroethyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6R,8aR)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6R,8aS)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6S,8aR)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((6S,8aS)-octahydroindolizin-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(3-chloro-5-fluoropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(3-chloro-5-fluoropyridin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,3R)-3-(3,3-difluoropyrrolidin-1-yl)-2,2,4,4-tetramethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,3S)-3-(3,3-difluoropyrrolidin-1-yl)-2,2,4,4-tetramethylcyclobutyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-(2-fluoro-2-methylpropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-(2-fluoro-2-methylpropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-6-methyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-6-methyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((S)-3-methyl-4,5,6,7-tetrahydro-1H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(((R)-3-methyl-4,5,6,7-tetrahydro-1H-indazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-7-fluoro-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-7-fluoro-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-methylpyridazin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-chloro-2-methylpyrimidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloropyrazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-methoxypyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(pyridin-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(pyridin-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-cyanopyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(oxetan-3-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(3-cyanoazetidin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-methyl-5-(trifluoromethyl)oxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(oxetan-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(oxetan-3-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-methylpyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(1,1-difluoro-3-methoxypropyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-(1,1-difluoro-3-methoxypropyl)-4-hydroxycyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1s,4R)-4-amino-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-amino-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3,5-difluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2S,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2R,4S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2R,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (2S,4R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-methylpiperidine-4-carboxamide; (S)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (2R,4S)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2S,4R)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2S,4S)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (2R,4R)-2-ethyl-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)piperidine-4-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-fluoro-3-(4-methylpiperazin-1-yl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5R,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5S,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5S,8r)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5R,8s)-4,4-difluoro-1-oxaspiro[4.5]decan-8-yl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((1-fluorocyclopropyl)methyl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,2-dimethylpiperidine-4-carboxamide; (R)-1-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2,2-dimethylpiperidine-4-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-(hydroxymethyl)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-(hydroxymethyl)-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(1-(tert-butylsulfinyl)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4S,7r)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4R,7s)-3,3-difluoro-1-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(4-hydroxybicyclo[2.2.2]octan-1-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(4-hydroxybicyclo[2.2.2]octan-1-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((4,6-dimethylpyridazin-3-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((5-chloropyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3S,4R)-4-morpholinotetrahydrofuran-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3R,4S)-4-morpholinotetrahydrofuran-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)ethyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrazolo[1,5-a]pyridin-7-ylmethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(oxetan-3-yl)piperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-morpholinocyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1s,4R)-4-morpholinocyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,5S,7r)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,5S,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(methylsulfonyl)piperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(oxetan-3-yl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(oxetan-3-yl)piperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4S)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4S)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4R)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4R)-4-fluoro-1-methylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,6S)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,6R)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,6R)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,6S)-1,6-dimethylpiperidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-fluoroethyl)-2,2-dimethylpiperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-fluoroethyl)-2,2-dimethylpiperidin-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3R,4R)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4S)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3S,4R)-4-fluoro-1-(6-methylpyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-methylpyrimidin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-methylpyrimidin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-(trifluoromethyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((S)-tetrahydrofuran-3-yl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-((R)-tetrahydrofuran-3-yl)azetidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-((3-chloro-5-(3,5-dimethylpiperazin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-N-(4-(1,1-difluoro-2-hydroxyethyl)-4-hydroxycyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-((1-(trifluoromethyl)cyclopropyl)methyl)pyrrolidin-3-yl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (1R,3s,5S)—N-(4-cyano-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)—N-((1s,4R)-4-(cyanomethyl)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1r,4S)-4-(cyanomethyl)-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((2-(2-fluoro-2-methylpropyl)-2-azabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (1R,3s,5S)-N-(4-amino-4-(trifluoromethyl)cyclohexyl)-8-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-8-azabicyclo[3.2.1]octane-3-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(2-(2-fluoro-2-methylpropyl)-2-azabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-(trifluoromethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4r)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-2-oxa-5-azaspiro[3.5]nonane-8-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-((R)-1-hydroxyethyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(5-((S)-1-hydroxyethyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(oxetan-3-yloxy)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-((5-(3,5-dimethylpiperazin-1-yl)pyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-cyanocyclopropyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(2-methoxy-5-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1,6,6-trimethylpiperidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(1H-pyrazolo[3,4-b]pyridin-4-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N—((R)-1-(1H-pyrazolo[3,4-b]pyridin-4-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-6-methylpyrazin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(6-methylpyridazin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(6-methylpyridazin-4-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(2-methylpyrimidin-5-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(2-methylpyrimidin-5-yl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-((3-hydroxyoxetan-3-yl)methyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-((3-hydroxyoxetan-3-yl)methyl)pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxypyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-cyanopyrimidin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)pyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(1-(3,5-dichloropyridin-2-yl)cyclopropyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(2,2-difluoro-3-hydroxypropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(2,2-difluoro-3-hydroxypropyl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,4S)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,4R)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-((R)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-((S)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((R)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((S)-1-oxa-6-azaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-3-chloropyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-3-chloropyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-((R)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-((S)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-((R)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-N-((S)-1-((S)-1-oxaspiro[3.3]heptan-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1,4,5-trimethyl-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-((1S,2S)-2-cyanocyclopropyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5-((1R,2R)-2-cyanocyclopropyl)pyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluoropyrazolo[1,5-a]pyridin-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-fluoropyrazolo[1,5-a]pyridin-7-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1S,6R)-2,5-diazabicyclo[4.1.0]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-((1R,6S)-2,5-diazabicyclo[4.1.0]heptan-2-yl)pyrimidin-2-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-((1-hydroxycyclopropyl)methyl)pyrrolidin-3-yl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-((1-hydroxycyclopropyl)methyl)pyrrolidin-3-yl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(pyrrolidin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyanopyrimidin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyanopyrimidin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3R,4S)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,3S,4R)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,3R,4S)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,3S,4R)-3,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)ethyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((5-(trifluoromethyl)-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; 4-(5-(2-acetyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((S)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((S)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((R)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(5-fluoro-2-((R)-1-hydroxyethyl)pyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-cyclopropyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-cyclopropyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-((1S,2S)-2-(hydroxymethyl)cyclopropyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((3-((1R,2R)-2-(hydroxymethyl)cyclopropyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((2-((3S,5R)-3,5-dimethylpiperazin-1-yl)-5-(trifluoromethyl)oxazol-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-ethyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-fluoropyridin-2-yl)methyl)-4-(5-(2-ethyl-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-chloro-5-methoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-(trifluoromethyl)-2-((3S,5R)-3,4,5-trimethylpiperazin-1-yl)oxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-5-azaspiro[3.5]nonane-8-carboxamide; (R)-5-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-5-azaspiro[3.5]nonane-8-carboxamide; (S)—N-(5-cyanopyrazolo[1,5-a]pyrimidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(1-(6-cyanopyridin-3-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-1-(5-cyanopyridin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-1-(5-cyanopyridin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((S)-4,4-difluoro-1-(5-methylpyrazin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((R)-4,4-difluoro-1-(5-methylpyrazin-2-yl)pyrrolidin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-isopropoxypyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(5-fluoro-2-methoxy-3-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxy-3-methylpyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(6-acetylpyrazolo[1,5-a]pyridin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-((S)-1-hydroxyethyl)pyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(6-((R)-1-hydroxyethyl)pyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)-N-(7',8'-dihydro-6'H-spiro[oxetan-3,5'-quinoline]-8'-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (7S)—N-(5-ethyl-2-oxa-5-azaspiro[3.5]nonan-7-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(5,5-dimethyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1-(aminomethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3R,4S)-3-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3S,4R)-3-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((4-(trifluoromethyl)-1H-imidazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2R,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2S,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2R,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2S,4S)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2R,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1S,2S,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2R,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((1R,2S,4R)-2,4-dihydroxy-4-(trifluoromethyl)cyclohexyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)isoxazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-cyclopropylpyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)—N-((3-cyclopropylpyridin-2-yl)methyl)-4-(3-(5-fluoro-2-methylpyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-4-(trifluoromethyl)-1H-pyrazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-5-(trifluoromethyl)-1H-1,2,3-triazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(((S)-3,3-difluoropiperidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-(((R)-3,3-difluoropiperidin-4-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((5-fluoropyrimidin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-5-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-5-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((4-(trifluoromethyl)pyridin-3-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((2-methyl-4-(trifluoromethyl)thiazol-5-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((R)-1-(hydroxymethyl)-3-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((S)-1-(hydroxymethyl)-3-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-(trifluoromethyl)-1H-imidazol-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-(1-(hydroxymethyl)-2-oxabicyclo[2.1.1]hexan-4-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((3-chloro-5-(4-methylpiperazin-1-yl)pyridin-2-yl)methyl)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3S)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3S)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1R,3R)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1S,3R)-3-hydroxy-3-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-N-((3-(trifluoromethyl)pyridin-4-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)—N-((5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)-4-(3-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-5-carbonyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxy-3-(trifluoromethyl)pyridin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(6-cyanopyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(6-cyanopyrimidin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(2-chloro-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4S)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (R)-4-(5-(2-chloro-5-fluoropyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((1r,4R)-4-hydroxy-4-(trifluoromethyl)cyclohexyl)-4-azaspiro[2.5]octane-7-carboxamide; (S)-4-(5-(5-fluoro-2-methoxypyridin-4-yl)-1H-pyrazole-3-carbonyl)-N-((5-methoxy-3-(trifluoromethyl)pyrazin-2-yl)methyl)-4-azaspiro[2.5]octane-7-carboxamide and pharma- ceutically acceptable salts thereof.
28. 28. The compound or pharma- ceutically acceptable salt of any one of claims 1 to 27, having a TR-FRET inverse agonist AC50 value of less than 1000 nM, less than 500 nM, or less than 250 nM.
29. R 1 The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 27, wherein m is 0.
30. R 8 Or R 9 9. The compound or pharma- ceutically acceptable salt of claim 8, wherein: is a spiro-linked oxetane.
31. The compounds have formula (IIB) and formula (IIIB): [C20] (In the formula, q is 0 or 1; and R 8 and R 9 are each independently selected from hydrogen, halogen, hydroxyl, optionally substituted alkoxy, and optionally substituted alkyl.
31. The compound or pharma- ceutically acceptable salt according to any one of claims 1 to 30, selected from the compounds of
32. A pharmaceutical composition comprising at least one compound or salt selected from the compounds of formula (I) according to any one of claims 1 to 31 and pharma- ceutically acceptable salts thereof.
33. 33. The pharmaceutical composition of claim 32, further comprising at least one pharma- ceutically acceptable carrier.
34. A pharmaceutical composition described in claim 32 or 33, for use in the treatment or prevention of cancer.
35. 35. The pharmaceutical composition of claim 34, wherein the cancer is selected from bladder cancer, breast cancer, prostate cancer and cancers with altered RXRα and / or PPARγ pathways.
36. The pharmaceutical composition of claim 34 or 35, wherein the cancer is bladder cancer.
37. 37. The pharmaceutical composition of claim 36, wherein the bladder cancer is selected from advanced bladder cancer, luminal bladder cancer, and basal cell bladder cancer.
38. The pharmaceutical composition according to any one of claims 34 to 37, wherein the cancer is a chemotherapy-resistant and / or immunotherapy-resistant cancer.
